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Abstract
There is increasing recognition that aberrant protein modifications play an
important role in the pathophysiology of inflammation and oxidative stress in cells. We
recently discovered that N6-formylation of lysine is an abundant endogenous
modification of histone and chromatin proteins. The high abundance of N 6-formyllysine
in histone proteins and its chemical similarity to the biologically important N6_
acetyllysine has raised questions about its mechanisms of formation and biological
consequences. Using novel ultrasensitive and specific liquid chromatography-coupled
tandem mass spectrometry methods (LC-MS/MS) to quantify N6-formyllysine lesions in
proteins, we aimed to investigate the sources as well as the fate of this abundant
endogenous protein modification. We present evidence that endogenous formaldehyde is
a major source of N6-formyllysine and that this adduct is widespread among proteins in
all cellular compartments. We observed in vitro as well as in vivo that formaldehyde
exposure leads to a dose-dependent increase in N6 -formyllysine protein adducts, with the
use of isotopically-labeled formaldehyde to dissect endogenous from exogenous
formaldehyde as sources of the adduct. Further, other isotope labeling studies revealed
that lysine demethylation in histone proteins is not a source of N -formyllysine. With
regard to N6-formyllysine persistence in cells, our investigation of histone deacetylases
revealed that despite chemical similarity of N6-formyllysine to N6-acetyllysine, the
former is refractory to removal by histone deacetylases, which suggests that they will
persist throughout the life of individual histone proteins. If not repaired, lysine
formylation could accumulate to significant levels. The resemblance of N -formyllysine
to N 6-acetyllysine, together with recent studies that mapped its location on many
conserved lysine acetylation and methylation sites along histone proteins, support the
idea that this abundant protein modification could interfere with normal regulation of
gene expression, potentially leading to an epigenetic mechanism of disruption of cell
function.
Thesis Supervisor: Peter C. Dedon
Title: Professor of Toxicology and Biological Engineering
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Chapter 1: Introduction
Goals and summary of this thesis
This thesis project is focused on defining the mechanism of formation and biological
significance of N6-formyllysine, a recently discovered abundant endogenous secondary
modification of proteins that resembles the physiologically important N6-acetyllysine in
histone proteins. This thesis is organized in 5 chapters. Chapter 1 presents a
comprehensive review of protein secondary modifications with an emphasis on lysine
acetylation, due to the resemblance of N6-formyllysine to N6-acetyllysine. The chapter
subsequently discusses the role of reactive oxidants and electrophiles in generating
pathological modifications of proteins and then focuses on N6-formyllysine and its
potential effects in terms of disrupting the epigenetic roles of histone modifications.
Chapter 2 provides detailed development of an ultrasensitive and specific liquid
chromatography-coupled tandem mass spectrometry method for quantifying this adduct
in proteins. Topics such as distribution of this adduct among different histone classes,
mechanisms for N6-formyllysine generation in addition to the DNA oxidation pathway
we originally reported, as well as its possible pathological consequences in cells are
explored in Chapter 3, with the discovery of formaldehyde as a major endogenous source
of N6-formyllysine. Chapter 4 extends our studies to measurement of N -formyllysine
protein adducts in tissues of rats exposed to formaldehyde by inhalation. In Chapter 5,
we conclude this thesis by summarizing our results regarding sources as well as fate of
N 6-formyllysine adducts and assess possible biological significance of this secondary
protein modification, particularly in terms of interfering with regulatory roles of histones.
N 6-Formylation of lysines in histones may represent an epigenetic mechanism of
disruption of cell function leading to cancer and other diseases.
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Post-translational modifications of proteins and their regulatory roles
In eukaryotes, the level of complexity of the proteome is several orders of magnitude
greater than what is dictated by its genome sequence [1], with each gene effectively
encoding several proteins. In addition to alternative RNA splicing that generates
different mRNA transcripts from a single gene [2], the post-translational modification of
proteins (PTMs) significantly enhances the complexity of the proteome [1,3]. This type
of protein modification involves covalent alterations of the polypeptide backbone or side
chains, leading to changes in a protein's structure and/or function [1,3,4]. In most cases,
these modifications are reversible and under tight regulation of specific enzymes [5].
Eukaryotes dedicate a relatively high percentage of their genomes to enzymes modulating
PTMs. For instance, in humans, greater than 5% of the genes encode such enzymes [3].
Protein modifications modulate protein-protein and protein-nucleic acid
interactions and regulate the cellular environment by affecting a multitude of biological
functions and processes such as protein activity, localization, turnover, signaling
cascades, and cellular metabolism [1,5,6]. It is then of no surprise that dysregulation of
PTMs leads to a plethora of disorders and diseases.
From more than 300 PTMs discovered to date [5], the most common are
phosphorylation, acetylation, methylation, glycosylation, hydroxylation, palmitoylation,
sulfation, and ubiquitination [1,2,5], as briefly discussed:
- Phosphorylation. Phosphorylation and dephosphorylation of serine, threonine,
or tyrosine residues mediated by protein kinases (PKs) and phosphatases (PPs),
respectively, is a key modification with many roles in regulating cellular
16
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physiology and metabolism, mainly through modulating enzymatic activities and
intracellular signaling pathways [2,7,8].
- Methylation. Another key PTM is methylation of lysine and arginine. Specific
residues in histones as well as non-histone proteins such as p53, NF-cB, ERa are
subject to methylation in cells [9]. In histones, lysine methylation is dynamically
regulated by histone methyltransferases and histone demethylases, with important
roles in gene expression and chromatin organization [10]. Protein methylation, in
addition to DNA methylation/demethylation, has implications in embryonic and
postnatal development [1,11,12].
- Glycosylation. Protein glycosylation, or the addition of sugar moiety to proteins,
is an enzymatic mediated and reversible PTM [13], as opposed to the random
non-enzymatic glycation that mostly renders proteins inactive [14]. Protein
glycans formed by glycosylation have important structural and modulatory roles
such as recognition elements for glycan binding proteins (GBPs), and therefore
regulate a variety of processes such as development and survival [15].
" Hydroxylation. Hydroxylation of amino acids such as proline, asparagine,
phenylalanine, tryptophan, and tyrosine is mediated by enzymes called
hydroxylases [16,17]. Hydroxylation is critical in cellular detoxification reactions
[1], as well as in the structural stability of proteins (e.g., hydroxyproline is an
essential element of collagen) [18].
- Palmitoylation. Covalent attachment of fatty acids to proteins is another type of
PTM. S-Palmitoylation of the cysteine thiol is a reversible modification with
important physiological roles in G-protein-coupled receptor (GPCR) trafficking
17
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and protein activity, as well as localization (as attachment of the hydrophobic
moiety is important for membrane association) and T-cell signaling [19,20].
- Sulfation. The post-translational sulfation of tyrosine residues, a common
modification of secreted and transmembrane proteins, has essential roles in
chemokine signaling, leukocyte adhesion, immune response, extracellular
protein-protein interactions, intracellular protein transport, protein activity and
degradation [21-23].
- Ubiquitination. Ubiquitination is a covalent attachment of ubiquitin (Ub) to
lysine residues of proteins in order to tag them for degradation and recycling.
Attachment of Ub to proteins is a multi-step process, carried out in order with a
set of 3 enzymes: Ub activating enzymes (El), Ub conjugating enzymes (E2), and
Ub ligases (E3) [24]. The Ub tag (mediated by mono-Ub or poly-Ub), is a crucial
protein modification for proteasomal degradation, intracellular signaling cascades,
protein binding, localization, and activity [25,26].
- Acetylation. Lysine acetylation is a key protein modification with inherent
importance to this thesis due to the chemical similarity of lysine acetylation to
lysine formylation and the critical role of lysine acetylation of histone proteins in
regulating gene expression. To address this phenomenon, the next section of
thesis introduction addresses histone protein structure and function followed by
the biochemistry of histone acetylation.
18
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Histone proteins and their post-translational modification
In eukaryotes, histone proteins are intimately associated with DNA and a plethora of
other protein complexes forming chromatin [27,28]. The fundamental repeating unit of
eukaryotic chromatin is nucleosome, an octamer of core histones (consisting of two H2A-
H2B dimers and a H3-H4 tetramer) around which 147 base pairs of DNA are tightly
wrapped in a left-handed super-helix 1.7 times around the core octamer [29-32]. The
linker histone HI binds the nucleosome and locks in place the DNA wrapped around the
core histones [33-35]. Additionally, it binds to linker DNA (10-60 base pairs of DNA
linking the nucleosomes) and allows for formation of the beads on a string structure and
higher order assemblies, such as 30 nm solenoids and 100 nm fibers [32,34,36].
Chromatin is a dynamic structure, capable of unfolding and refolding [37], with two
general states of tightly compact heterochromatin and the more open euchromatin that are
in general associated with transcriptionally silent and active genomic regions,
respectively [38,39].
In addition to serving as structural scaffolds for packaging DNA inside the
nucleus, histones have regulatory roles affecting a variety of cellular processes such as
chromatin organization and gene expression [33,40,41]. Besides the globular domains,
all core histones have long (-20-35 residues) and highly conserved amino-terminal tails
that protrude from the histone core domain [42] and compose -25-30% of the mass of
individual histones [43]. An exception is the histone H2A that has an additional long
carboxyl terminal segment protruding from the nucleosome [37]. These tail domains
may be structured or unstructured, may interact with nucleosomal or linker DNA, and
participate in protein-protein interactions [44].
19
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Histone tail segments, rich in basic amino acids, are subject to a variety of post
translational modifications including acetylation, methylation, phosphorylation,
ubiquitylation, and ADP ribosylation with some locations modified in more than one way
[30,31,40,45,46]. For instance, acetylation can occur on lysines, methylation on lysines
and arginines, phosphorylation on serines and threonines, and ubiquitylation and
sumoylation on lysines. Just to add to the complexity, lysine can be mono-, di-, and tri-
methylated, and arginine can be mono- and di-methylated. Most of these enormous
secondary modifications identified to date occur on the long amino-terminal regions of
histones, although there are some that occur on the main globular region [37]. Singly or
in combination, these secondary modifications can act as "control switches" and play
diverse regulatory roles in chromatin remodeling, regulation of transcription, DNA
repair, and replication [40,47,48]. For instance, in higher eukaryotes, the combination of
H3 K14 acetylation, H4 K8 acetylation, and H3 S10 phosphorylation usually signals
transcriptional activation, and tri-methylation of H3 K9 and the lack of H3 and H4
acetylation are associated with transcriptional repression [37]. It is thought that through
these covalent modifications the tail structure or contacts change, thus modulating
histone:DNA interactions as well as creating new sites of dynamic interactions that can
attract binding of regulatory proteins and affect the chromatin stability and DNA
accessibility within the nucleosomes [40,44,49].
Most physiological histone modifications have been shown to be dynamic,
reversible, and under regulation of histone modifying enzymes [30]. An exception is
arginine demethylation during which arginine is changed into citrulline [30]. Lysine
acetylation in histone proteins is among the best characterized PTMs [50], with inherent
20
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CH 3  H
NH NH
H2CH2
(CH 2)3  (CH 2)3
/CH /CH
N N 'C
H " H C
N-Acetyllysine N-Formyllysine
Figure 1-1. Lysine formylation is a chemical homolog of lysine acetylation.
importance to this thesis due to chemical similarity of N6-acetyllysine to N6 -formyllysine
(Figure 1-1). The following section presents a detailed review of lysine acetylation.
Lysine acetylation is a key regulatory post-translational modification
Acetylation of the lysine E-amino group is an abundant protein modification with key
regulatory roles in transcription factors, histone proteins, and other chromatin proteins.
Histone acetylation is among the best characterized PTMs [50] in its regulation of
chromatin organization, gene expression, and DNA repair [36]. Lysine acetylation
occurs at highly conserved sites along the tails of core histones and is under tight control
of two sets of enzymes: histone acetyl transferases (HATs) and histone deacetylases
(HDACs) (Figure 1-2) [51]. HATs transfer an acetyl group from acetyl coenzyme A to
conserved lysine residues while HDACs catalyze the removal of the acetyl moiety
[39,52]. In addition to disrupting the DNA/histone electrostatic interactions, acetyl lysine
is recognized by the bromodomains of chromatin remodeling proteins, which in turn
recruit other downstream factors involved in chromatin remodeling and DNA
21
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CH3
Acetyl- 0=NH/NH2  CoA CoA H NH
H2C H2C
(CH2)3  (CH 2)3
/C H C /CHN C HDAC N IC
H 0 Acetate H20 H 6
Lysine N6-Acetyllysine
Figure 1-2. Lysine acetylation is under tight control of two sets of enzymes: histone
acetyl transferases (HATs) and histone deacetylases (HDACs).
transcription [48,53]. Acetylation is almost exclusively associated with transcriptional
activation [30]. The chemical similarities of N6 -formyllysine and N6 -acetyllysine (Figure
1-1) suggest a disruptive role for the former in signaling by histone acetylation. Indeed,
N 6-formyllysine has been detected at conserved sites of lysine acetylation and
methylation in histone proteins [35,54].
The state of acetylation in cells is also important in the pathophysiology of a
variety of diseases including neurodegenerative diseases. For instance, it has been shown
that p-amyloid hyperacetylation and acetylation of tau proteins are associated with
Alzheimer's disease and dementia, respectively [1]. However, dysregulation of
physiological and (in most cases) enzymatically controlled protein modifications are not
the only ones affecting cellular physiology and disease. Protein modification by reactive
oxidants and electrophiles constitute an important change to protein structure and/or
function. The next sections examine some of the sources of these damaging agents and
the protein modifications that they produce.
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Production of reactive chemical species in cells
A wide range of physiological or pathophysiological processes in cells generate oxidants
and electrophiles that directly damage biomolecules or lead to the formation of other
reactive intermediates [55,56], thus affecting crucial cellular processes.
One source involves inflammation. As shown in Figure 1-3A, during
inflammation, activated macrophages and neutrophils produce a variety of highly reactive
oxygen and nitrogen species as part of the host defense system against pathogens. These
highly reactive species alter cellular biomolecules through oxidation, nitrosation,
nitration, and halogenations among other reactions [57]. The membrane-bound NADPH
oxidase of these inflammatory cells catalyzes the transfer of an electron from NADPH to
02, forming the superoxide anion radical (O2' ) [58]. 02' is not a strong oxidant, but it
is a precursor to other reactive species [59]. Most cellular 02' is converted to hydrogen
peroxide (H20 2) via superoxide dismutase (SOD) [55,59]. A range of potent oxidants
and oxidation/nitration intermediates are produced as H2 0 2 and 02' react with other
molecules (Figure 1-3A). H20 2 can be reduced to the highly reactive hydroxyl radical
(HO') by redox reactive metals (e.g., Fe2+ and Cue') via Fenton chemistry. Reaction of
O2' with nitric oxide (NO) produced by activated macrophages in high concentration
( 1p.M) [60,61] at sites of inflammation, yields peroxynitrite (ONOO-). ONOOH
(protonated form of ONOO~) undergoes rapid homolysis (t1/2 ~1 s) to produce HO' and
the weak oxidant, nitrogen dioxide radical (N0 2') [55,57]. Reaction of ONOO- with
carbon dioxide generates a potent nitrating agent, nitrosoperoxycarbonate (ONOOC0 2 ),
that upon homolysis (t1/2 ~ 50 ms) forms carbonate radical anion (CO3't) and N0 2' [57].
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A
Illustration by Jeff Dixon, copyright Peter C. Dedon.
B
ATP synthase particles
Intermembrane space
Ribosomne rsa
Granule
Ou embran
Deoxyribonucleic acid (DNA)
1 e~ SOD
02 -+ 02' -+ H20 2
Figure 1-3. Generation of reactive oxygen and nitrogen species.
Inflammation (A) and mitochondrial respiration (B), are two major
sources for generation of reactive species. A and B are reproduced from
[57] and [64], respectively.
Another nitrosating agent, nitrous anhydride (N20 3), is derived from oxidation of NO. In
activated neutrophils, myeloperoxidase-mediated reaction of H20 2 with Cl- yields
hypochlorous acid (HOCl), a strong oxidizing and halogenating agent [62].
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Myeloperoxidase in these cells also mediates the conversion of nitrite (NO2) to N0 2'
[63].
The other sources of reactive oxygen species include mitochondrial respiration
(Figure 1-3B) and other 02 metabolism pathways. The use of molecular 02 for the
cellular production of energy is responsible for the generation of many reactive oxygen
species [65]. A variety of reactive molecules and free radicals are derived from 02 such
as 02' , HO', H20 2, peroxyl radical (ROO'), ozone (03), and singlet oxygen (102).
Reactive species such as 02' and H20 2 are produced as a result of electron leakage from
the mitochondrial electron transport chain during normal cellular metabolism [66,67].
Oxidoreductase enzymes such as NADPH oxidase, myeloperoxidase, and the cytochrome
P450 enzymes also produce reactive species [68].
Reactive oxygen and nitrogen species have the capability of damaging molecules
directly. However, damage caused by these reactive species (e.g., lipid peroxidation,
carbohydrate oxidation, and direct amino acid oxidation), can yield electrophiles capable
of causing further damage to biomolecules [55] (Figure 1-4). For instance, electrophilic
species such as reactive aldehydes and epoxides are formed as a result of lipid
peroxidation and can react with nucleophilic sites in DNA and proteins to yield adducts
[55,69]. Among the products generated, the ap-unsaturated aldehydes possessing two
reactive sites are especially important since they can form cross-links or cyclic adducts
with protein or nucleic acid [70-72]. Pathological modifications in proteins can be
readily formed through reaction of nucleophilic amino acids lysine, histidine, and
cysteine with reactive electrophiles generated from oxidation of polyunsaturated fatty
25
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acids and carbohydrates such as malondialdehyde, 4-hydroxy-2-nonenal (HNE), 4-
oxononenal, and glyoxal [73-77].
The next chapter covers in more detail these adventitious protein modifications
due to reaction with primary and secondary reactive species. It should be noted that
protein oxidative modification can result from other sources such as xenobiotics, cigarette
smoke, acetaminophen, y-irradiation, ultraviolet (UV) light, and ozone [68], among other
agents. However, for the purpose of this thesis, we only focus on protein damage due to
endogenously derived reactive oxidants and electrophiles.
From amino acid oxidation
H
N
'
glutamate semialdehyde
(from proline or arginine)
H
N
0
Aminoadipate semialdehyde
(from lysine)
acrolein
(from threonine)
From lipid oxidation
O OH O O CO2H
OH OH
malondialdehyde (MDA) 4-hydroxy-2-nonenal (HNE) 9-hydroxy-1 2-oxo-1 0-dodecenoic acid
(HODE)
From carbohydrate oxidation
o i 0
glyoxal
0 o
methylglyoxal
OH OH
HO 
O
OH 0
3-deoxyglucosone
Figure 1-4. Examples of reactive aldehydes generated from damage to biomolecules.
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Protein damage due to reactive endogenous oxidants and electrophiles
In addition to physiological secondary modifications that are mostly enzymatically
regulated, proteins are subjected to reactions with endogenous oxidants and electrophiles
generated by oxidative stress, inflammation, and normal cell metabolic processes [77-80].
Protein targets of reactive species are vast and include structural and membrane proteins,
metabolic and detoxification enzymes, or proteins involved in cell signaling and gene
expression [55]. Protein modification caused by a single oxidant or electrophile, such as
HNE can produce a diverse set of cellular responses with hundreds of genes upregulated
and downregulated [58]. Here we review representative examples of the types of damage
caused by these reactive species in cells.
Direct oxidation of amino acid side chains is one example of adventitious protein
modification. Oxidative modification of proteins is usually specific to type and location
of the residue and may occur on polypeptide backbone or the nucleophilic/redox-
sensitive side chains. As mentioned previously, modifications of proteins affect their
function in a positive or negative way, thus playing important roles in cellular physiology
as well as progress of disease. Cysteine, tyrosine, and methionine are among the amino
acids mostly modified by endogenous oxidants [55]. Cysteine sulfenic acid is formed via
oxidation of the sulfhydryl group of cysteine, helping to absorb the oxidative insult [81].
Cysteine sulfenic acid is unstable and forms disulfide bonds with glutathione or other
accessible thiols or undergoes further oxidation to cysteine sulfinic acid and cysteine
sulfonic acid [82]. S-nitrosylation of cysteine and 3-nitration of tyrosine residues in
proteins is another consequence of oxidative or nitrosative stress [83,84]. In fact, 3-
nitrotyrosine is used as a biomarker of protein damage associated with inflammation and
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variety of diseases [84]. Methionine oxidation to form methionine sulfoxide, reversed by
methionine sulfoxide reductases, is speculated to serve as a defense mechanism against
oxidative stress by preventing other residues from oxidative damage [85]. Elevated
levels of oxidized aromatic amino acid residues (e.g., 3-nitrotyrosine, 3-chlorotyrosine,
and 3,4-dihydroxylphenylalanine) are seen in age-related diseases such as
neurodegenerative and cardiovascular diseases [55]. For instance, 3-nitrotyrosine
adducts were detected in tyrosine hydroxylase isolated from brain tissues of Parkinson's
disease model mice that exhibited reduced enzymatic activity [86]. Oxidation of proline,
arginine, and lysine residues result in protein carbonyls such as glutamate and
aminoadipate semialdehydes [73,78]. In general, protein carbonyls can be generated via
direct damage to polypeptide backbone, oxidation of amino acids proline, lysine,
arginine, threonine, glutamate, aspartic acid [1,55,73,78], or Michael addition of reactive
a4-unsaturated aldehydes to nucleophilic amino acids lysine, histidine, and cysteine [73-
77]. Protein carbonylation, an irreversible modification, often leads to loss of protein
function [87]. Indeed, total protein carbonyl content is regarded as a biomarker of
oxidative stress and inflammation and elevated levels are associated with a variety of
human diseases such as cardiovascular and neurodegenerative disorders, and processes
such as aging [73,75,78].
Another adventitious protein modification involves reaction of amino acid side
chains with physiological sugars and sugar oxidation products. Unlike the enzymatic
mediated and site specific glycosylation of proteins, these advanced glycation end
products (AGEs) are random events [1]. For instance, the reactive dicarbonyl sugar 3-
deoxyglucosone, synthesized via the Maillard reaction and the polyol pathway [88],
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results in formation of AGEs such as imidazolone, N6-carboxymethyllysine, and
pyrraline by reaction with amines [89] (Figure 1-5). AGEs have been shown to cause
extracellular matrix dysfunction, to react with cell receptors and change cytokine and
hormone levels, and to alter functions of a variety of intracellular proteins [90]. AGEs
can also form crosslinks, especially in long lived proteins such as collagen and elastin
[91]. The formation and accumulation of AGEs over time has been implicated in the
development of diabetes as well as age-related degenerative processes by damaging
blood vessels, connective tissue, ocular lens, and nerves [14,90].
Reactive aldehyde induced modifications of proteins typically arise by reaction of
the nucleophilic side chains of lysine, cysteine, and histidine with reactive electrophiles
such as malondialdehyde (MDA), 4-hydroxynonenal (HNE), acrolein, and glyoxal
generated by oxidation of polyunsaturated fatty acids and carbohydrates, among other
Lipid peroxidation adducts
s OH OH OH
Lys-N CH3  N-Lys 0ONH S
Lys Cys
lysine-HNE lysine-HNE cysteine -HNE
dihydropyridine-lysine Schiff base Michael adduct Michael adduct
AGEs
N H 
0
HOOC N..) OH HOOC N O
H NH2  NH2
imidazolone N6-carboxymethyllysine N6-3-formyl-3,4-dehydropiperidino-lysine
Figure 1-5. Examples of protein adducts caused by reactive electrophiles.
29
Chapter 1: Introduction
biomolecules [74,75,77,79,80]. Michael adducts are among the major adducts formed,
for example, from the reaction of MDA with lysines residues (Figure 1-5) and 4-hydroxy-
2-alkenals with lysine, cysteine, and histidine amino acids [55]. Sequential addition of
two acrolein molecules to epsilon-amino group of lysine results in formation of cyclic
N6-3-formyl-3,4-dehydropiperidino-lysine adduct [92] (Figure 1-5). Schiff base adducts
are formed from reaction of 4-hydroxy-2-alkenals [93] as well as formaldehyde with
lysine residues [94]. Protein adducts generated by products of lipid peroxidation can alter
protein function and thus affect the vast range of biological functions they regulate,
leading to pathological processes associated with human diseases [77-80,95]. For
instance, HNE induces cell toxicity by covalently modifying IxB kinase, thus inhibiting
the subsequent transcription of NFKB-dependent genes needed for cell survival [58]. It
was also shown that HNE results in loss of microtubule network in neuroblastoma cells
by forming Michael adducts with tubulin isoforms [96].
Among adventitious protein adducts (Table 1-1 and Figure 1-5), N6-formylation
of lysine has recently emerged as an abundant protein modification [35,53,54,97]. N6_
Formyllysine is a chemical homolog of the biologically important N6-acetyllysine and
thus may interfere with acetylation signaling in cells. The following section is a more
detailed introduction on this pathological protein modification that was originally
observed in histones and chromatin proteins.
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Table 1-1. Examples of oxidative modification of proteins.
Adapted from [68].
Oxidative Modification Amino Acids Residue
Disulfides, glutathiolation Cys
S-Nitrosocysteine Cys
3-Nitrotyrosine Tyr
3-Chlorotyrosine Tyr
Methionine sulfoxide Met
Cross-links, aggregates Several
Lipid peroxidation adducts Lys, Cys, His
Carbonyls All (Lys, Arg, Pro, Thr)
Amino acid oxidation Lys, Cys, His
N6-Formyllysine as an adventitious protein modification
Emerging evidence points to widespread modification of cellular proteins by N6_
formylation of lysine as a result of adventitious reactions with endogenous electrophiles
[35,53,54,97]. These adducts were originally described in histones and other chromatin
proteins [35,53,54], although they have since been identified as adducts arising in
proteins subjected to nitrosative and oxidative stresses [97].
We have previously shown the generation of N6-formyllysine adducts in histone
proteins as a result of DNA oxidation [53]. Histones are rich in nucleophilic amino acids,
such as lysine and arginine that can react with pathogenic electrophiles generated from
oxidized DNA, proteins, and lipids [53]. Our previous study in which DNA was labeled
with 5' tritiated thymidine followed by cell treatment with neocarzinostatin (an enediyne
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Figure 1-6. Generation of N6 -formyllysine as a result of DNA oxidation. 3'-
Formylphosphate residues are generated during 5'-oxidation of 2-deoxyribose in
DNA (A). The formyl moiety can be transferred to lysines in histone proteins to
form N 6-formyllysine (B) [53].
antibiotic that abstracts a 5'-H from 2-deoxyribose) showed that lysines in histones can
react with 3'-formylphosphate residue, an electrophile generated from 5'-oxidation of 2-
deoxyribose in DNA, to form N6-formyllysine (Figure 1-6) [53].
N 6-Formyllysine was reported to be the major adduct formed when proteins were
reacted with trichloroethylene (TCE) oxide in vitro [98], and a recent study points to its
formation in proteins treated with biological oxidant, peroxynitrite [97], suggesting other
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sources for its generation besides DNA oxidation. In 1985, N 6-formyllysine was reported
to be formed by reaction of 1-lysine with formaldehyde [99] and recently, it was shown it
could result from silver staining procedures that involve the use of formaldehyde [100].
Considering that formaldehyde reacts with amines to give a carbinolamine intermediate
that is only one oxidation state away from a formamide functional group, we
hypothesized that endogenous formaldehyde could serve as a major source of N6_
formyllysine residues in histone and other proteins.
Formaldehyde is a reactive aldehyde forming adducts with nucleophilic sites in
DNA and protein molecules resulting in products such as N 2-hydroxymethyl-dG DNA
adducts [101] and formaldehyde induced Schiff bases on lysine residues of histones [94],
in addition to protein-DNA crosslinks. It has been classified as a known human
carcinogen by the International Agency for Research on Cancer in 2005 [102] and by the
National Toxicology Program of the National Institute of Environmental Health Sciences
in 2011 [103], although it is still considered a probable human carcinogen by the U.S.
Environmental Protection Agency [104]. In addition to environmental and occupational
sources [101,105,106], formaldehyde arises endogenously from cellular processes such as
demethylation of histones and nucleic acids as well as biosynthesis of purines, thymidine,
and some amino acids [10,105,107]. Formaldehyde is a relatively abundant metabolite at
concentrations ranging from 13 to 97 pM in human plasma [105]. Thus, formaldehyde
induced N 6-formyllysine generation in proteins could be the major source of this adduct
compared to previous sources reported.
The relatively high abundance of N 6-formyllysine adducts in histones [35,53]
suggests it could interfere with the regulatory roles of histones. The following section
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examines the potential disruptive role of N 6-formyllysine in cellular epigenetics.
The biological implications of N -formyllysine modification of histones
N -Formyl lysine has been reported to be a major protein adduct in histones occurring on
many conserved lysine residues involved in epigenetic regulations [35,53]. Even the
DNA oxidation pathway in itself can result in high abundance of this adduct in histones.
Indeed, there are thousands of oxidative events in a cell on a daily basis, resulting in
hundreds of deoxyribose oxidations in DNA with each site producing different
electrophilic products, leading to fonnation of 10's of N6-formyllysines per cell per day
[53,108]. As discussed later in this thesis, formaldehyde is found to be another major
source giving rise to this adduct in histones. Therefore, if not removed, this pathological
modification may accumulate to significant levels in cells.
The high rate of occurrence of N6-formyllysine in histones raises the possibility of
epigenetic interferences through affecting the regulatory roles of these proteins. In
chromatin proteins, N6-formyllysine has the potential to interfere with important
physiological modifications that perform signaling functions. Indeed, N6-formyllysine
has been detected at conserved sites of lysine acetylation and methylation in histones
[35,54]. In addition, the chemical similarities of N6-formyllysine and N6-acetyllysine
suggest a disruptive role for the former in signaling by histone acetylation. Thus, this
thesis project is focused on defining the mechanism of formation and biological
significance of N 6-formyllysine. To that end, we developed an ultrasensitive and specific
liquid chromatography-coupled tandem mass spectrometry method for quantifying this
adduct in proteins (Chapter 2), and used it to answer questions about its mechanisms of
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formation and pathological consequences in cells (Chapter 3). Chapter 4 extends our
studies to measurement of N6-formyllysine protein adducts in tissues of rats exposed to
formaldehyde by inhalation, as we discovered formaldehyde to be a major endogenous
source of N 6-formyllysine (Chapter 3). We conclude this thesis in Chapter 5 by
summarizing our results regarding sources as well as fate of N6-formyllysine adducts and
assess possible biological significance of this secondary protein modification. The
presence of N 6-formylation of lysines in histones may have important biological
consequences leading to pathology and progress of variety of diseases.
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Abstract
The initial step in investigating the mechanism of formation of N6-formyllysine and
assessing its possible pathological consequences in cells involved developing an
ultrasensitive and specific liquid chromatography-coupled tandem mass spectrometry
(LC-MS/MS) method for quantifying this adduct in proteins. The quantification method
we developed previously (Jiang et al. PNAS 104: 60-5, 2007) proved to be relatively
insensitive and biased, so a new method was developed, which involved proteolytic
hydrolysis of proteins to individual amino acids, normal phase chromatographic
resolution of the amino acids followed by tandem electrospray mass spectrometry to
quantify them. N6-Formyllysine is reported as a percentage of total lysines in order to
normalize it across samples with different amounts and types of proteins. The use of
Streptomyces griseus protease greatly diminished the background levels of lysine and
formyllysine observed previously with proteinase K. Further, the direct analysis of
amino acids, as opposed to phenylisothiocyanate (PITC) derivatization, improved both
the sensitivity and specificity of the assay. In addition to lysine and N6-formyllysine
species, N6-acetyl, mono-, di-, and tri-methyllysine modifications are monitored, with
limit of detection of 1-50 fmol for all species. Measurement of N6-formyllysine in
histones of TK6 cells indicates that this adduct is an abundant endogenous protein
modification (~1 per 104 lysines). In addition, the dilution rate of the absolute quantity of
N -formyllysine in histone proteins of TK6 cells (grown in media containing isotopically
labeled lysine) reveals that N6-formyllysine is a rather stable modification of histones,
with a half-life closely matching TK6 cell doubling rate.
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Introduction
The first step in defining the biological relevance of a new molecule is to quantify its
presence in cells and tissues. With this in mind, a new method was developed to quantify
the N 6-formyllysine protein adducts. The method workflow shown in Figure 2-1 involves
hydrolysis of proteins to generate individual amino acids that are then analyzed using
liquid chromatography-coupled tandem mass spectrometry. Each step in the method is
critical to the precision and accuracy of the analytical data.
Proteolytic digestion using proteinase K has been utilized previously for
generating individual amino acids containing N6-formyllysine moiety [1,2] in order to
avoid removal of the formyl group by traditional strong acid-mediated protein hydrolysis.
However, we found that proteinase K undergoes extensive autolysis and, when used in
small quantities to avoid self digestion, it was not an efficient protease. The next step of
chromatographic resolution of amino acids was previously accomplished with PITC
derivatization and reversed phase HPLC. However, this approach decreased the
sensitivity of the method and added an extra step. The final step of tandem mass
spectrometric quantification of the amino acids is relatively straight forward.
This chapter covers the new enzyme discovered as well as other advancements to
our previous method to make it more reliable and sensitive and presents an example of its
immediate applications (i.e., determining the rate of dilution of this adduct in cells). We
extend our quantitative analysis of proteins to include other lysine modifications such as
acetylation and methylation besides formylation. We report the development of a highly
robust and sensitive LC-MS/MS method for measuring all N6-formyl, -acetyl, and -
methyllysine modifications, with limits of detection of 1-50 fmol for all species. In
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Digestion to amino
acids using
S. griseus protease
'I
Quantification of
lysine adducts
using LC-MSIMS
Figure 2-1. The overall strategy for quantifying lysine
adducts of interest in proteins.
addition to providing insights into N6-formyllysine content of proteins, there are
numerous applications of this method for characterizing the chemical biology of this
protein modification as presented in the subsequent chapters.
Materials and Methods
Materials. Lysine internal standard, 4,4,5,5,-[2H]-Lysine, was purchased from
Cambridge Isotope Laboratories (Andover, MA). N6 -Formyllysine internal standard,
4,4,5,5-[ 2H]-N 6-formyllysine, was synthesized from 4,4,5,5-[2H]-lysine according to
Jiang et al. [1]. N -Acetyllysine internal standard, 3,3,4,4,5,5,6,6-[2 H]-N 6-acetyllysine
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was obtained from CDN Isotopes (Pointe-Claire, Quebec, Canada). Lysine, N 6_
formyllysine, N 6-acetyllysine, Streptomyces griseus protease, and protease inhibitor
cocktail (for use with mammalian cell and tissue extracts) were obtained from Sigma-
Aldrich (St. Louis, MO). N -Mono-methyllysine, N6-di-methyllysine, and N6 -tri-
methyllysine were purchased from Bachem Bioscience Inc. (King of Prussia, PA).
Nonidet P-40 was from Roche Diagnostic Corporation (Indianapolis, IN). Human
lymphoblastoid TK6 cell line was a generous gift of Wogan Lab at Massachusetts
Institute of Technology.
TK6 cell culture and labeling. TK6 cells were cultured in RPMI 1640 medium
(Cellgro, Manassas, VA) supplemented with 10% heat-inactivated horse serum (Atlanta
Biologicals, Lawrenceville, GA), 10,000 U penicillin/ml and 10,000 ptg streptomycin/ml
(Lonza, Walkersville, MD), and 2mM L-glutamine (Lonza, Walkersville, MD) at 370 C
in a 5% CO 2 atmosphere. For labeling proteins with endogenous isotopically labeled N6_
formyllysine, TK6 cells were grown in a customized RPMI-1640 medium, with
everything identical to traditional RPMI 1640 medium (supplemented with horse serum,
antibiotics, and L-glutamine), except for the presence of deuterated lysine
(3,3,4,4,5,5,6,6-[ 2H]-Lysine) instead of non-labeled lysine. After one week of growth
(roughly 9 doubling times) in the customized medium, cells were washed and
resuspended in non-labeled RPMI medium. Histones were extracted from -10 million
cells at Oh, 18h, 36h, and 54h, and the quantity of isotopically labeled formyllysine, as a
percentage of total labeled and unlabeled lysines, was measured at each of those time
points.
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Histone extraction from TK6 cells and bovine liver tissue. Extraction of histones was
performed according to Boyne et al. [3], with modifications. Cells (~10 7 per sample)
were pelleted by centrifugation at 1000 x g for 5 min at 4 'C and the pellet was washed
once with PBS. Cell pellets were then lysed by resuspension in ice-cold lysis buffer (15
mM Tris-HCl, pH 7.5, 15 mM NaC1, 60 mM KCl, 1 mM CaCl2, 5 mM MgCl 2, 250 mM
sucrose, 1 mM dithiothreitol, 10 mM sodium butyrate) containing a 100:1 v:v dilution of
protease inhibitor cocktail in the presence of 0.03% Nonidet P-40 and incubation on ice
for 5 min with occasional gentle mixing. Nuclei were pelleted by centrifugation at 600 x
g for 5 min at 4 'C, and the pellet was washed twice with ice-cold lysis buffer without
Nonidet P-40. Histones were extracted by addition of ice-cold 0.4N H2 SO 4 and
incubation overnight on ice. The solution was centrifuged at 3000 x g for 5 min and
proteins in supernatant were precipitated by addition of 20% v/v trichloroacetic acid and
overnight incubation at 4 'C. Samples were then centrifuged at 14000 x g for 10 min at
40C, washed once with ice-cold acetone containing 0.1% HCl, and once with ice-cold
acetone. The extracts were air-dried and stored at -20 0 C until use. For extracting
histones from bovine liver tissue, 20 mg of tissue was cut into small pieces and washed
with PBS. Chromatin bound fraction was obtained using the Subcellular Protein
Fractionation Kit from Thermo Scientific (Waltham, MA) and a Kontes all-glass Dounce
homogenizer (10 strokes with a type B pestle). Proteins in chromatin bound fraction
were precipitated by addition of 20% v/v trichloroacetic acid and overnight incubation at
4 'C. Samples were then centrifuged at 14000 x g for 10 min at 4 'C, washed once with
ice-cold acetone containing 0.1% HCl, and once with ice-cold acetone. The extracts were
air-dried and stored at -20 0 C until use.
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Purification of individual histones. HPLC purification of total histones was performed
according to Boyne et al. [3], with modifications. Total histones ( 50 pg) were
dissolved in 0.1% trifluoroacetic acid (TFA) in water and fractionated by HPLC on an
Agilent 1100 series instrument (Agilent Technologies, Santa Clara, CA), using a Source
5RPC C18 reversed-phase column (4.6 x 150 mm, 5 jim particles; GE Healthcare Life
Sciences). The mobile phase flow rate was 1 mL/min and the solvent system was 0.1%
TFA in water (A) and 0.094% TFA in acetonitrile (B) with the elution starting at 0% B,
linearly increasing to 28% B over 28 min, reaching 37% B at 70 min, 38% B at 100 min,
60% B at 150 min, and finally 100% B at 151 min, before the column was re-equilibrated
to 0% B for 10 min. Protein elution was monitored by UV absorbance at 214 nm and
histones in each fraction were tentatively identified by resolution on a 13% SDS-PAGE
gel with Coomassie Blue staining (see Figure 3-S1).
Enzymatic hydrolysis of proteins. Histones extracted from TK6 cells and other protein
samples were dissolved in 50 piL of 100 mM ammonium bicarbonate buffer (pH 8.5),
4,4,5,5-_[2H]-lysine (2 nmol),4,4,5,5-[ 2H]-N 6-formyllysine (1 pmol), and 3,3,4,4,5,5,6,6-
[2H]-N 6-acetyl lysine (10 pmol) were added as internal standards, and the proteins
hydrolyzed by addition of Streptomyces griseus protease (freshly prepared solution each
time) with incubation at 37 'C for 16 h. S. griseus was used at a ratio of 1 pg of
enzyme per 10 pg of protein. Samples were then dried under vacuum and resuspended in
50 piL of water before mass spectrometry analysis.
Quantification of amino acids. N -Formyllysine and other amino acids were quantified
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as a percentage of the total quantity of lysine, by liquid chromatography-coupled mass
spectrometry (LC-MS/MS). HPLC was performed with an Agilent 1100 series
instrument. Adducts of interest (Figure 2-2) in the resuspended protein hydrolysates
were separated using an aqueous normal phase Cogent diamond hydride column (2.1 x
150 mm, 4 pm) from MicroSolv Technology Corporation (Eatontown, NJ). The mobile
phase flow rate was 400 IL/min, and the column temperature was maintained at 20 *C.
The solvent system was 0.1% acetic acid in water (A) and 0.1% acetic acid in acetonitrile
(B), with the elution starting at 100% B, the gradient linearly decreased to 25% B over 30
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H
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IIH2N- CH'C'.OH
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Figure 2-2. The structure and MW of lysine species monitored.
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min, stayed at 25% B for 3 additional min before the column was re-equilibrated at 100%
B for 7 min. In order to separate the co-eluting M+1 citrulline signal from M+2 ion of
N 6-formyllysine, an extended chromatography run time was used, with the elution
starting at 100% B, the gradient linearly decreased to 75% B over 75 min, further
decreased to 25% B over the next 3 min, reached 15% by 83 min before the column was
re-equilibrated at 100% B for 7 min. The species of interest were then analyzed using an
Agilent 6410 triple quadrupole mass spectrometer (MS/MS) equipped with an
electrospray ionization (ESI) source operated in positive ion mode. The operating
parameters were as follows: ESI capillary voltage, 4000 V; gas temperature, 350 'C;
drying gas flow, 12 L/min; and nebulizer pressure, 30 psi. Selected reaction monitoring
(SRM) transitions are summarized in Table 2-1. Note that in addition to chromatographic
separation and presence of internal standards, the unique product ions of m/z 112 and m/z
126 for formyl and acetyl lysines, respectively, distinguish them from their isobaric
compounds di- and tri-methyl lysines (Table 2-1 and Figure 2-3). The fragmentor
voltage and collision energy were optimized in order to maximize the signal of each
product ion monitored (Figure 2-4) and are summarized in Table 2-1. 4,4,5,5-[ 2H]-
lysine, 4,4,5,5-[ 2H]-N 6-formyllysine, and 3,3,4,4,5,5,6,6-[ 2H]-N 6 -acetyl lysine were used
as internal standards and external calibration curves for methyl species were prepared
using deuterated acetyl lysine (Figure 2-5).
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Table 2-1. Summary of mass spectrometry parameters for each species.
SRMInternal Qualifier Ion Fragmentor Collision
Species Transition Standard Transition Voltage EnergyTranitio Transition (I/) (V) (V)(m/z) (m/)/V)(V
Lysine 147 -130 151 ->134 NA 100 8
N6-Formyllysine 175 ->112 179 -116 NA 105 10
N6 -Acetyllysine 189-> 126 197-> 134 NA 105 10
N6 -Mono- 161 84 NA 161 130 100 10
methyllysine
N6-Di- NA 100 14
methyllysine 175 -+ 84 175 -+ 130
N -Tri- NA 100 14
methyllysine 189 -> 84 189 -> 130
N*+
O=C N
CH3
m/z 126
HNQ
0
H2N,, OH
CH2
CH2
CH 2
mCH 2
mlz 130
Figure 2-3. Proposed structures for product ions monitored.
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Figure 2-4. Examples of product ions for each lysine species monitored, after
optimization. In all cases, the highest count was used as the product ion for MRM
transitions in triple quadruple mass spectrometer, as described in Materials and
Methods. An exception was lysine, for which the 130 m/z ion was selected due to
lysine's high abundance compared to other species monitored.
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Figure 2-5. Examples of calibration curves for the isotope dilution LC-MS/MS
analysis of lysine species, as described in Materials and Methods. Abbreviations: FK,
N6-formyllysine; DFK, deuterium-labeled N6-formyllysine; AK, N6 -acetyllysine;
DAK, deuterium-labeled N -acetyllysine; K, lysine; DK, deuterium-labeled lysine;
MK, N -mono-methyllysine; M 2K, N6-di-methyllysine; M 3K, N 6-tri-methyllysine.
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Results
An improved method to quantify N'-formyllysine in proteins. Our previous method
for quantifying N6-formyllysine in proteins involved proteinase K-mediated hydrolysis of
proteins, derivatization of the resulting amino acids with PITC, HPLC pre-purification of
amino acid derivatives, and final LC-MS/MS analysis of the derivatized amino acids [1].
This method proved to be relatively insensitive and biased as a result of using proteinase
K, which produced only partial hydrolysis of some proteins when used in small quantities
to minimize background autolysis (Figure 2-6). To overcome these problems, we used
Streptomyces griseus protease at a ratio of 1 pg enzyme per 10 pg proteins, which
resulted in efficient and complete digestion of all proteins as judged by the total amount
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Figure 2-6. Comparison of released lysine in protein digestion using Streptomyces
griseus protease versus proteinase K. Proteinase K produced only partial hydrolysis of
TK6 histone proteins when used in small quantities to minimize background autolysis.
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of lysine released per pg of purified histone proteins (Figure 2-6). In addition, the
method was optimized to eliminate the HPLC pre-purification step and the need for PITC
derivatization to achieve chromatographic resolution of amino acids. This was achieved
using aqueous normal phase HPLC with a diamond-hydride column to resolve individual
amino acids. This chromatographic system resolved N6-acetyllysine, mono-, di-, and tri-
N6-methyllysines, as well as N6-formyllysine and lysine, as shown in Figure 2-7. With
isotopically labeled internal standards added prior to protease digestion, identification
and quantification of amino acids were accomplished by isotope-dilution LC-MS/MS in
positive ion mode, using multiple reaction monitoring (MRM) transitions. The limits of
detection were found to be 1 fmol for N6-formyl- and N6-acetyllysine, 10 fmol for lysine,
and 50 fmol for each of N6-mono-, di-, and tri-methyl lysine. Data for the various lysine
modifications are expressed here as proportions of the total number of lysines in the
sample.
Measurement of N6-formyllysine adducts in total histone proteins. The first
application of the new method involved quantification of the various modified lysines in
a mixture of total histone proteins extracted from TK6 lymphoblastoid cells (Table 2-2).
Data show that N6-formylation of lysine occurs at a low frequency (e.g., 1 per 104
lysines) in total histones compared to higher frequencies of acetylation and methylation
(40 - 230 per 104 lysines). Further, an analysis of total histone proteins, either extracted
from TK6 cells or from commercial sources, show a similar background level of N6_
formyllysine in all samples (Table 2-3). The next chapter covers the distribution of
various lysine adducts in different classes of histones separated by HPLC.
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Table 2-2. Quantification of lysine modifications in a sample of total histone proteins.
Formyll Acetyl Methyl Dimethyl Trimethyl
TK6 1.0 0.12 40 10 230 50 130 40 25 5Cells
'Column titles denote different N6-modifications of lysine.
2Data are expressed as modifications per 104 total lysines and represent mean ± SD
for 3 biological replicates.
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Figure 2-7. An example of different lysine species detected in purified histone H4
from TK6 cells. Lysine adducts were monitored by tandem mass spectrometry, as
described in Materials and Methods.
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Table 2-3. Quantification of N 6-Formyllysine in total histones.
N -FormyllysineHistone source (per 104 Lys)
TK6 cells 1.0 ± 0.1
Calf thymus 2± 0.2
Bovine liver 2 ± 0.6
Resolving co-elution problem of a contaminant with M+2 ion of N -formyllysine. In
addition to monitoring N6-formyllysine ion (m/z transition of 175 -> 112), some
applications of the quantification method, as will be discussed in Chapters 3 and 4,
involve monitoring the heavy isotope of N 6-formyllysine (m/z transition of 177 -+ 114).
However, we encountered the presence of 177 m/z ion in control samples (without the
heavy isotope) that was well beyond the background abundance of M+2 ion of N6_
formyllysine (-0.7%), suggesting the co-elution of a contaminant peak with the analyte.
We have determined the contaminant to be the M+1 ion of citrulline (Figures 2-8 and 2-
9) and thus substantially extended the chromatography to separate the two.
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Figure 2-8. Citrulline co-elutes with M+1 ion of N6-formyllysine. The co-eluting
peaks of equal amounts of citrulline and N6-formyllysine standards injected (A), are
separated by substantially extending the chromatography (B). C is the comparison of
the product ion of citrulline standard with the product ion of the co-eluting peak in a
total histone sample from bovine liver.
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Figure 2-9. An example of co-elution of a contaminant peak with M+2 ion of N6_
formyllysine in total histone sample from bovine liver. In applications that require
monitoring the heavy isotope of N6-formyllysine (m/z transition of 177 --+ 114), the
co-eluting peaks (A) are separated by substantially extending the chromatography (B).
Measuring the rate of dilution of N'-formyllysine. The next application of the method
involved determining the rate of loss of N6-formyllysine in TK6 cells containing
isotopically-labeled lysine in proteins. The chemical similarity of N6-formyllysine and
N 6-acetyllysine (Figure 1-1) suggested that the former might be subject to removal by
histone deacetylases [4] or other protein repair or degradation processes. The dilution
experiment was based on labeling TK6 cell proteins with [2H8]-lysine by growing the
cells in customized RPMI medium containing 3,3,4,4,5,5,6,6-[ 2H]-lysine for one week
prior to resuspending them in non-labeled medium. Due to the average doubling time of
18 h for TK6 cells, histones were extracted at 0 h, 18 h, 36 h, and 54 h, corresponding to
0-3 replication cycles. The quantity of [2Hs]-N6 -formyllysine, as a percentage of total
labeled and unlabeled lysines, was then measured at each time point (Figure 2-10A). A
62
Chapter 2: Development of an LC-MS/MS method for quantification of N-formyllysine adducts in protein
comparison of labeled and unlabeled lysine signals revealed > 90% labeling of all lysines
and modified lysines, including N6-formyllysine. Upon removal of the [2H 8]-lysine, the
rate of loss of [2H8]-N 6-formyllysine in histones was detected by mass spectrometry as
ions that are 8 mass units heavier than the unlabeled counterparts. The results show a
dilution rate of 15 ± 0.5h for [2H8]-N 6 -formyllysine, which closely matches the cell
doubling time of 16 ± 0.9h for this experiment (calculated based on [2H8]-lysine dilution
curve as shown in Figure 2-1 OB).
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Figure 2-10. Dilution rate of N -formyllysine in TK6 cells. The rate of dilution of
[2Hs)-N 6-formyllysine (A) closely matches the exact cell doubling time calculated based
on [ Hs]-lysine rate of dilution (B).
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Discussion
We set out to develop a highly sensitive and specific LC-MS/MS method to accurately
quantify N6-formyllysine lesions in proteins extracted from cells and tissues, as a first
step towards defining the biological relevance of lysine N -formylation. The
quantification method we developed previously [1] proved to be relatively insensitive and
biased, and thus major improvements were required. We were able to implement
significant improvement to increase the efficiency as well as sensitivity and specificity of
our previous N6-formyllysine quantification method.
First, we discovered and optimized a new proteolytic enzyme, Streptomyces
griseus protease, that proved to be highly efficient at digesting proteins to individual
amino acids compared to proteinase K previously used (Figure 2-6). Using proteinase K
at concentrations low enough to prevent the autolysis of enzyme resulted in only 10%
digestion compared to complete digestion performed by comparable amount of S. griseus
enzyme. In addition, we extended our quantitative analysis of proteins to include other
lysine modifications such as acetylation and methylation besides formylation, and
utilization of the new highly efficient enzyme allowed for detection of all lysine species
(Table 2-2).
The HPLC step was further optimized to make the method more robust. The pre-
purification step was eliminated and the need for PITC derivatization for
chromatographic resolution of amino acids with reversed phase HPLC, was obviated by
switching to normal phase HPLC. We were able to achieve baseline separation of
analytes of interest in the resuspended protein hydrolysates (Figure 2-7). The elimination
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of the derivatization step removed an extra step and further enhanced the sensitivity of
the method.
The identification and quantification of amino acids were accomplished by
isotope-dilution LC-MS/MS in positive ion mode, using MRM transitions. The
discovery of the unique product ions of m/z 112 and m/z 126 for formyl and acetyl
lysines, respectively, distinguished them from their isobaric compounds di- and tri-
methyl lysines (Table 2-1 and Figures 2-3 and 2-4) while lowering the limits of detection
by more than 10 fold (10 fmol to 1 fmol). The optimization of fragmentor voltage and
collision energies (Table 2-1 and Figure 2-4) further decreased the limits of detection for
all species. The new sensitive and specific method allows for robust quantification of all
N6-methyl-, -acetyl- and -formyl-lysine modifications, with limits of detection of 1 fmol
for N6 -formyl- and N6-acetyllysine, 10 finol for lysine, and 50 frnol for each of N6 -mono-
di-, and tri-methyl lysine.
In addition to providing insights into N 6-formyllysine content of proteins, there
are numerous applications of our quantification method for characterizing the chemical
biology of this protein modification, as presented in the subsequent chapters. Here, we
provided two examples of its immediate application. The first example was
quantification of the background levels of lysine adducts in a sample of total histones
extracted from TK6 cells. As shown in Table 2-2, N6-formyllysine adducts occur at a
low frequency (e.g., 1 per 10 4 lysines) in total histones compared to higher frequencies of
acetylation and methylation (40 - 230 per 104 lysines). The next chapter covers the
distribution of N6-formyllysine adducts in different classes of histones separated by
HPLC. Our quantification data is consistent with published studies of relative quantities
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of histone modifications using immunologic and radiolabeling techniques [5-8].
Moreover, using our sensitive methods, we report ~1 lysine formylation per 104 lysines in
total histones extracted from TK6 cells compared to 4-10 modification per 104 previously
reported [1].
The other application of the quantification method presented here was to
determine the rate of dilution of [2H 8]-N6 -formyllysine in TK6 cells. Data showed that
the dilution rate of 15 h for [2H]-N6 -formyllysine closely matches the cell doubling time
of 16 h (Figure 2-10), suggesting that N6-formyllysine is either a stable modification of
histones or is formed and removed at the same frequency, resulting in no overall change
in its steady state levels. The observation that cell replication did not result in an
apparent repair or removal of N6-formyllysine adducts in histone proteins is consistent
with a previous study of conservation of histone carcinogen adducts during replication
[9].
Our robust and sensitive analytical method could readily be extended for
quantification of other amino acid modifications in proteins, with the advantage of using
a highly efficient yet mild proteolytic digestion as opposed to the traditionally used
strong hydrochloric acid for protein hydrolysis that could remove the adduct of interest.
The absolute quantification of a specific protein modification, in addition to mapping
studies, could provide insights on various biological pathways in cells. For instance,
mapping studies of N6-formyllysine sites reveal that this adduct occurs on conserved
lysines involved in epigenetic regulation [5], and through absolute quantification, we
showed that this modification is rather stable or is formed and removed at the same
frequency, resulting in no overall change in its steady state levels. Furthermore, this
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method is used in subsequent chapters to quantify various lysine modifications in
individual classes of histones. Histone modification-based signaling involves the
location and number of specific modification targets within a histone protein as well as
the frequency of modification of a target among all copies of a particular histone protein.
Our quantification data provide some insight into this issue. Further, N6-formyllysine
quantification is used to prove possible mechanisms for its formation and shed light on its
fate.
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Quantitative analysis of histone modifications:
Formaldehyde is a source of pathological
N6-formyllysine that is refractory to histone
deacetylases
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Abstract
Aberrant protein modifications play an important role in the pathophysiology of many
human diseases, in terms of both dysfunction of physiological modifications and the
formation of pathological modifications by reaction of proteins with endogenous
electrophiles. Recent studies have identified a chemical homolog of lysine acetylation,
N 6-formyllysine, as an abundant modification of histone and chromatin proteins, one
possible source of which is the reaction of lysine with 3'-formylphosphate residues from
DNA oxidation. Using a new liquid chromatography-coupled to tandem mass
spectrometry method to quantify all N -methyl-, -acetyl- and -formyl-lysine
modifications, we now report that endogenous formaldehyde is a major source of N6_
formyllysine and that this adduct is widespread among cellular proteins in all
compartments. N -Formyllysine was evenly distributed among different classes of
histone proteins from human TK6 cells at 1-4 modifications per 10 4 lysines, which
contrasted strongly with lysine acetylation and mono-, di- and tri-methylation levels of
1.5-380, 5-870, 0-1400 and 0-390 per 104 lysines, respectively. While isotope labeling
studies revealed that lysine demethylation is not a source of N6-formyllysine in histones,
formaldehyde exposure was observed to cause a dose-dependent increase in N6-
formyllysine, with use of [13C, 2 H2 ]-formaldehyde revealing unchanged levels of adducts
derived from endogenous sources. Inhibitors of class I and class II histone deacetylases
did not affect the levels of N6-formyllysine in TK6 cells and the class III histone
deacetylase, SIRTI, had minimal activity (<10%) with a peptide substrate containing the
formyl adduct. These data suggest that N6-formyllysine is refractory to removal by
histone deacetylases, which supports the idea that this abundant protein modification
could interfere with normal regulation of gene expression if it arises at conserved sites of
physiological protein secondary modification.
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Introduction
In addition to physiological secondary modifications, proteins are subjected to reactions
with endogenous electrophiles generated by oxidative stress, inflammation, and normal
cell metabolic processes [1-5]. These adventitious or pathological modifications
typically arise by reaction of the nucleophilic side chains of lysine, histidine, and cysteine
with reactive electrophiles such as malondialdehyde, 4-hydroxynonenal (HNE), and
glyoxal generated by oxidation of polyunsaturated fatty acids and carbohydrates, among
other biomolecules [2-4,6,7]. The resulting adducts, which can alter protein function and
lead to protein degradation, are associated with a variety of pathological processes and
human diseases [1-5,8]. Among these pathological adducts, N6-formylation of lysine has
recently emerged as an abundant protein modification [5,9-11]. While originally
described in chromatin proteins [9-11], it has since been identified as an adduct arising in
proteins subjected to nitrosative and oxidative stresses [5]. In chromatin proteins, N 6_
formyllysine has the potential to interfere with the functions of other post-translational
modifications that perform signaling functions [12-15], such as acetylation, methylation,
phosphorylation, ubiquitylation, and ADP ribosylation, with some locations modified in
more than one way (e.g., refs. [16-18]). The chemical similarities of N6-formyllysine and
N 6-acetyllysine suggest a disruptive role for the former in signaling by histone
acetylation. Indeed, N6-formyllysine has been detected at conserved sites of lysine
acetylation and methylation in histones [10,11].
While N 6-formyllysine adducts are now well recognized as abundant protein
modifications in cells, the source of these pathological adducts remains unclear. We
recently showed that some portion of N -formyllysine arises in chromatin proteins by
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reaction of lysine side chains with the 3'-formylphosphate residue derived from 5'-
oxidation of 2-deoxyribose in DNA in cells (Figure 3-1) [9]. However, the observation
of this adduct in proteins treated with the biological oxidant, peroxynitrite, suggests other
sources for the formyl species [5]. Considering that formaldehyde reacts with amines to
give a carbinolamine (N6-hydroxymethyllysine) intermediate that is only one oxidation
state away from a formamide functional group (Figure 3-1), we hypothesized that
endogenous formaldehyde could serve as a source of N6-formyllysine residues in histone
and other proteins. In addition to environmental and occupational sources [19-21],
formaldehyde arises from cellular processes such as oxidative demethylation of nucleic
acid and histone proteins, as well as biosynthesis of purines, thymidine, and some amino
acids [20,22,23], making it a relatively abundant metabolite at concentrations ranging
from 13 to 97 pM in human plasma [20]. To test this hypothesis and to clarify the
cellular locations and quantities of N 6-formyllysine relative to other major histone
modifications, we developed a novel liquid chromatography-coupled to electrospray
tandem mass spectrometry (LC-MS/MS) method to quantify all N6-methyl-, -acetyl-, and
-formyl-lysine modifications. Application of this method reveals that endogenous
formaldehyde is a major source of N 6-formyllysine, that this adduct is widespread among
proteins in all cellular compartments, and that, in chromatin proteins, it is refractory to
removal by histone deacetylases.
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Figure 3-1. Sources of N6-formyllysine. The adduct can be generated in chromatin
proteins from reaction of lysine with 3'-formylphosphate residue derived from 5'-
oxidation of 2-deoxyribose in DNA or from reaction of lysine with endogenous or
exogenous formaldehyde. Formaldehyde reacts with amines to give a carbinolamine
intermediate (N6-(hydroxymethyl)-lysine) that is in equilibrium with a Schiff base and
that is one oxidation state away from the formamide functional group of N6_
formyllysine.
Materials and Methods
Materials. Unlabeled and [13C, 2H2]-labeled formaldehyde were purchased as 37% and
20% aqueous solutions from Amresco (Solon, OH) and Isotec (Miamisburg, OH),
respectively. 4,4,5,5-[ 2H]-Lysine was purchased from Cambridge Isotope Laboratories
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(Andover, MA). 4,4,5,5-[2H]-N6-Formyllysine was synthesized from 4,4,5,5-[2H]-lysine
according to Jiang et al. [9]. 3,3,4,4,5,5,6,6-[ 2H]-N 6-acetyllysine were obtained from
CDN Isotopes (Pointe-Claire, Quebec, Canada). L-Methionine-([13 C 2H3 ]-methyl) was
obtained from Isotec (Miamisburg, OH). Lysine, N6-formyllysine, N6-acetyllysine,
bovine serum albumin, human recombinant HMG- 1, human IgG, Streptomyces griseus
protease, and protease inhibitor cocktail (for use with mammalian cell and tissue extracts)
were obtained from Sigma-Aldrich (St. Louis, MO). N6-Mono-methyllysine, N6-di-
methyllysine, and N6-tri-methyllysine were purchased from Bachem Bioscience Inc.
(King of Prussia, PA). Nonidet P-40 was from Roche Diagnostic Corporation
(Indianapolis, IN). Suberoylanilidehydroxamic acid (SAHA) and SIRTI (human
recombinant) enzyme were purchased from Cayman chemical (Ann Arbor, MI). Peptide
substrates for SIRTI (GGAKRHR and its lysine-acetylated and -formylated forms) were
synthesized at Massachusetts Institute of Technology Biopolymers Laboratory. The
human lymphoblastoid TK6 cell line was a generous gift of Prof. Gerald Wogan
(Massachusetts Institute of Technology).
TK6 cell culture, exposure, and labeling. TK6 cells were cultured in RPMI 1640
medium (Cellgro, Manassas, VA) supplemented with 10% heat-inactivated horse serum
(Atlanta Biologicals, Lawrenceville, GA), 10,000 U penicillin/ml and 10,000 ptg
streptomycin/ml (Lonza, Walkersville, MD), and 2 mM L-glutamine (Lonza,
Walkersville, MD) at 37 *C in a 5% CO2 atmosphere. For formaldehyde exposure
studies, TK6 cells were pelleted, washed, and resuspended in RPMI 1640 medium
without any supplements, prior to addition of formaldehyde to the medium. Following
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addition of formaldehyde, cells were incubated at 37 'C for 2 h with occasional mixing
prior to extracting chromatin proteins. Histones were extracted from ~107 cells after
exposure and the quantity of formyllysine, as a percentage of total lysine, was measured
as described below. For lysine demethylation studies, TK6 cells were grown in a
customized RPMI-1640 medium identical to the traditional medium (e.g., supplemented
with horse serum, antibiotics, and L-glutamine), except for the presence of labeled
methionine (L-methionine-([ 13C,2 H3]-methyl)) instead of non-labeled methionine.
Histones (from ~107 cells) were extracted every 2 d for 20 d in order to investigate the
formation of N 6[13C,2 H]-formyllysine. For histone deacetylase studies, TK6 cells were
incubated with the histone deacetylase inhibitor, SAHA, for 20 h at 37 'C in a 5% CO2
atmosphere prior to histone extraction. SAHA was dissolved in a 50:50 solution of
DMSO:PBS prior to addition to cell media. Control cells ( 107) were treated with the
DMSO:PBS vehicle.
Histone extraction from TK6 cells and subcellular protein fractionation from tissue.
For detailed procedure regarding histone extraction, refer to Materials and Methods
section of Chapter 2. For collecting membrane, cytosolic, and nuclear fractions from
tissues, 20 mg of bovine liver tissue was cut into small pieces and washed with PBS, and
proteins were fractionated using the Subcellular Protein Fractionation Kit from Thermo
Scientific (Waltham, MA) and a Kontes all-glass Dounce homogenizer (10 strokes with a
type B pestle). Proteins in subcellular extracts were precipitated by addition of 20% v/v
trichloroacetic acid and overnight incubation at 4 'C. Samples were then centrifuged at
14000 x g for 10 min at 4 'C, washed once with ice-cold acetone containing 0.1% HCl,
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and once with ice-cold acetone. The extracts were air-dried and stored at -20 0 C until
use.
Purification of individual histones. HPLC purification of total histones was performed
according to Boyne et al. [24] with modifications. For detailed procedure of histone
purification into individual amino acids, refer to Materials and Methods section of
Chapter 2.
Enzymatic hydrolysis of proteins. Proteins were hydrolyzed to individual amino acids
using S. griseus protease (freshly prepared solution each time) with incubation at 37 'C
for 16 h. For detailed procedure regarding protein digestion into individual amino
acids, refer to Materials and Methods section of Chapter 2.
Quantification of amino acids. N6-Formyllysine and other amino acids of interest were
quantified as a percentage of the total quantity of lysine, by liquid chromatography-
coupled mass spectrometry (LC-MS/MS). For detailed procedure regarding LC-MS/MS
based quantification of individual amino acids, refer to Materials and Methods section of
Chapter 2.
SIRTI peptide experiment. SIRTI peptide substrates (GGAKRHR, GGAKacetyiRHR,
and GGAKrmy1RHR) were HPLC purified on an Agilent 1100 series instrument using
Vydac 218TP52 C18 reverse-phase column (2.1 x 250 mm, 5 [im) from Grace Vydac
(Hesperia, CA). The mobile phase flow rate was 200 .L/min, and the column
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temperature was maintained at 30 'C. The solvent system was 0.05% trifluoroacetic acid
in water (A) and 0.05% trifluoroacetic acid in 80% acetonitrile (B), with the isocratic
elution of 5% B for the first 5 min, then a linear increase to 42% B over 25 min, reaching
100% B at 31 min followed by column re-equilibration at 5% B for 10 min. Each
purified SIRTi peptide substrate (100 pmol) was incubated overnight (12 h) at 25 *C
with 1 pg SIRTi, in 50 mM Tris-HCl (pH 8) buffer containing 137 mM NaCl, 2.7 mM
KCl, 1 mM MgCl 2, and 6 mM NAD*. The removal of acetyl and formyl groups from
SIRTi peptide substrates was determined using liquid chromatography-coupled mass
spectrometry. HPLC was performed on an Agilent 1100 series instrument using Agilent
Exclipse XDB C18 reverse-phase column (4.6 x 150 mm, 5 jim). The mobile phase flow
rate was 200 p.L/min, and the column temperature was maintained at 40 *C. The solvent
system was 0.1% acetic acid in water (A) and 0.1% acetic acid in acetonitrile (B), with
the elution starting at 20% B, the gradient linearly increased to 50% B over 5 min,
reached 100% B at 6 min, and kept at 100% B for 9 minutes before the column was re-
equilibrated at 20% B for 10 min. The species of interest were then analyzed using the
Agilent 6410 MS/MS system equipped with an electrospray ionization (ESI) source
operated in positive ion mode. The operating parameters were as follows: ESI capillary
voltage, 3500 V; gas temperature, 345 'C; drying gas flow, 8 L/min; and nebulizer
pressure, 30 psi. Multiple reaction monitoring (MRM) transitions were as follow:
GGAKRHR peptide, m/z 781.1 - 625.2; GGAKfrmyRHR peptide, m/z 809.4 -> 516.3;
and GGAKacetyiRHR peptide, m/z 823.4 -> 530.4. The fragmentor voltage and collision
energy were 200 V and 40 V for GGAKRHR peptide, respectively; 100 V and 46 V for
GGAKormy1RHR peptide; and 100 V and 52 V for GGAKacetyiRHR peptide.
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Results
Quantification of N -lysine modifications in proteins. In order to quantify N6-
formyllysine adducts, proteins are first subjected to proteolytic digestion to generate
individual amino acids that are then analyzed using our improved LC-MS/MS based
method, as outlined in detail in Chapter 2. To validate the new analytical method for
lysine modifications, we compared the frequency of N6-formyllysine among different
classes of histone proteins extracted from TK6 cells and resolved by reversed-phase
HPLC. As shown in Figure 3-S1A, all of the major histone classes were separated, with
further resolution of variant forms of histones HI and H3 (SDS-PAGE verification in
Figure 3-SiB), which is consistent with previous observations in cultured human cells
[10]. N6 -Formyllysine was detected in all histone classes at a frequency of 1-4
modifications per 104 lysines. This 3- to 4-fold variation among histone classes stands in
contrast to the 10- to 100-fold variation in the frequency of other modifications (Table 3-
1). The data in Table 3-1 represent the first absolute quantification of the various lysine
acetyl and methyl modifications in histone proteins, and are consistent with published
studies of relative quantities of histone modifications using immunologic and
radiolabeling techniques [10,25-27]. Histone modification-based signaling involves the
location and number of specific modification targets within a histone protein, as well as
the frequency of modification of a target among all copies of a particular histone protein.
Our data provide some insight into this issue. For example, we observed low-level
acetylation and methylation in histone HI, which is consistent with studies using
radiolabeled acetate [25], while this low level of modification maps to specific sites in the
globular domain and N-terminal tail of histone HI [10]. This low-level of acetylation
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and methylation in histone Hi stands in contrast to the high level of acetylation of H2,
H3 and H4 (Table 3-1), which is again supported by studies using radiolabeled acetate
[25].
Table 3-1. Quantification of lysine modifications in HPLC-purified histone proteins.1
Formy12 Acetyl Methyl Dimethyl Trimethyl
H1 (1)' 1.5 0.33 1.6 ±0.2 8.0 ±2.0 ND ND
11 (2)1 1.2 0.2 1.5 ±0.3 7.0 ±2.0 ND ND
112A 2.7 0.2 26 ±20 20 8 60 ±30 ND
H2B 1.7 0.7 66 ±20 5.0 7.0 ND 85 30
H3(1)1 3.9 0.5 280 ±130 680 80 1100 ±220 220 60
H3(2)1 3.6 1.3 380 ±100 870 30 1400 ±270 390 140
H4 2.6 0.4 73 ±60 260 80 740 ±40 3.0 6.0
'Classes of histone proteins resolved by reversed-phase HPLC, with putative
isoforms denoted in parentheses.
2Column titles denote different N6-modifications of lysine.
3Data are expressed as modifications per 104 total lysines and represent mean ± SD
for 3 biological replicates.
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The new analytical method was next applied to quantify N6-formyllysine in non-
histone proteins. We had previously observed N6 -formyllysine mainly in histone proteins
[9], perhaps as a result of biased proteolysis or subsequent steps in the technique.
However, using the new method, we are now able to detect N -formyllysine
modifications in a variety of different proteins, as shown in Table 3-2. Further, an
analysis of proteins in nuclear, cytosolic, and membrane compartments in bovine liver
revealed the presence of N6-formyllysine in all three locations (Table 3-2). These
observations are consistent with a source for N6-formyllysine other than the 3'-
formylphosphate residues of DNA oxidation previously identified for histone proteins
[9].
Table 3-2. Quantification of N6 -formyllysine in
different proteins.
N 6-FormyllysineIdentity of Protein ery 4NLysper 10 Lys
BSA 5±0.5
IgG 2 ±0.4
Collagen 2 ±0.5
HMG-l <0.2± 0.04
Bovine liver nuclear proteins 2 ± 0.6
Bovine liver membrane proteins 4± 1.0
Bovine liver cytosolic proteins 4± 0.6
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Formaldehyde as a source of N6-formyllysine. One alternative to 3'-formylphosphate
residues as a source of N6-formyllysine is oxidation of the carbinolamine (N6-
hydroxymethyllysine) intermediate in the reaction of formaldehyde with side chain amine
of lysine (Figure 3-1). To test this hypothesis, we performed a series of experiments,
starting with an in vitro reaction of L-lysine with different concentrations of
formaldehyde and quantification of N6-formyllysine. As shown in Figure 3-2A, there
was a concentration-dependent formation of N 6-formyllysine in reactions with
formaldehyde, presumably as a result of oxidation of the carbinolamine adduct by the
background of reactive oxygen species generated by trace metals and dissolved oxygen in
the solution. This dose-response relationship for N6-formyllysine formation was also
observed in histone proteins extracted from TK6 cells exposed to formaldehyde for 2 h at
37 'C (Figure 3-2B), with 10 mM formaldehyde producing roughly the same frequency
A B
C C
60 * 4
.~4
50*
340
c 30- 2
20-
10 *
. 0 0 W 
2 0 0.1 1 10 50 z 0 0.1 1 10
Formaldehyde (mM) Formaldehyde (mM)
Figure 3-2. Formaldehyde is a source of N6-formyllysine. Formation of N -
formyllysine in (A) in vitro reactions of 1 mM L-lysine with formaldehyde for 2 h at 37
0C, and in (B) TK6 cells exposed to formaldehyde, as described in Materials and
Methods. Data represent mean ± SD for N=3, with asterisks denoting statistically
significant differences by Students t-test (p < 0.05).
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of N6 -formyllysine in both in vitro and cellular studies (i.e., 6 per 104 lysine versus 3 per
104 lysine, respectively).
The relatively high endogenous levels of N6-formyllysine in histone and other
proteins (Tables 3-1 and 3-2) raised the question of the contribution of exogenous
formaldehyde exposures to the total load of N6-formyllysine in the cells. To address this
issue, we exposed TK6 cells to ["C,2H2 ]-labeled formaldehyde, which led to the
formation of N6_ 13C, 2H]-formyllysine that is 2 mass units heavier than the endogenous
adducts (Figure 3-3A). Following extraction of the histone proteins from formaldehyde-
treated TK6 cells (2 h, 37 C), both endogenous and exogenous N6 -formyllysine were
quantified by monitoring the transitions m/z 175 -> 112 and m/z 177 -> 114, respectively
(Figure 3-3A), with a third transition (m/z 179 -> 116) for the 4,4,5,5-[ 2H]-N 6_
formyllysine internal standard. As shown in Figure 3-3B, levels of endogenous
(unlabeled) N6-formyllysine remained constant at all concentrations of [ 3C,2H2]-
formaldehyde, while N6_[13C, 2H]-formyllysine increased as a function of the
concentration of labeled formaldehyde.
Lysine demethylation as a source of N -formyllysine. The enzymatic demethylation of
N 6-methyllysine modifications represents another possible source of N6-formyllysine in
histone proteins, given both the carbinolamine intermediate known to form during the
process of lysine demethylation and the ultimate release of the methyl group as
formaldehyde [23]. Adventitious oxidation of the carbinolamine intermediate or
secondary reaction of the released formaldehyde could result in the formation of N6_
formyllysine locally. To test these hypotheses, TK6 cells were grown in customized
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RPMI medium containing L-methionine with a ["C,2H3]-methyl group for 20 days to
label all methyl groups in N6-methyllysine species, and histone proteins were extracted
for analysis every 2 days. If N6-formyllysine is a product of disrupted lysine
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Figure 3-3. Addition of [13C,2H2 -formaldehyde to TK6 cells distinguishes exogenous
from endogenous sources of N -formyllysine. (A) LC-MS/MS analysis showing
signals for the three isotopomeric N6-formyllysine species, as described in Materials
and Methods. (B) Plot of N6-formyllysine levels as a function of exposure to [1c,2H2]-
formaldehyde. Data represent mean ± SD for N=3.
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demethylation in histones and is formed via oxidation of the carbinolamine intermediate
known to form during the process of lysine demethylation [23], or by reaction of lysine
with the formaldehyde released at the last step of successful lysine demethylation [23],
then one would expect to see an increase of 2 mass units corresponding to formation of
N6 [ 13C, 2H]-formyllysine (m/z 177 -+ 114 transition). In order to increase the signal-to-
noise ratio for N6 13C,2H]-formyllysine, N -formyllysine was HPLC-pre-purified in all
samples before LC-MS/MS analysis. Figure 3-4 depicts an example of the analysis using
the day 6 sample. As shown in Figure 3-4, N6-mono-methyllysine and N6-di-
methyllysine are predominately labeled (>90%) with heavy isotope methyl groups (i.e.,
[ 1C,2 H3]-methyl). In contrast to methyllysines, the level of N6-13C,2H]-formyllysine did
not increase beyond the natural isotope abundance level of -0.7% for the [M+2] ion of
N6-formyllysine (Figure 3-4C and Figure 3-S2). Note that the HPLC gradient was
changed here to fully resolve a contaminant signal from the TK6 cells (identified as the
[M+1] ion of citrulline) that otherwise co-eluted with N6-formyllysine and produced an
m/z value similar to the [M+2] isotopomer of N6-formyllysine.
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Figure 3-4. Analysis of lysine demethylation as a source of N6-formyllysine. Methyl
groups in N6-methyllysine species in TK6 cells were labeled using L-methionine-
([ 13C, 2H 3]-methyl) and N6-formyllysine and N6-methyllysine species were quantified
by LC-MS/MS as described in Materials and Methods. Panels A and B: N -mono-
methyllysine and N6-di-methyllysine are predominately labeled (>90%) with heavy
isotope methyl groups (mass increase of 4 m/z and 8 m/z, respectively), with <10% of
the modifications containing unlabeled methyl groups. Panel C: the level of N6[13C,
2H]-formyllysine (m/z 177 -* 114 transition) in histones did not show an increase
beyond the natural isotope abundance level of -0.7% for [M+2] ion of N6_
formyllysine.
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Persistence of N6 -formyllysine in cells. The chemical similarity of N -formyllysine and
N 6-acetyllysine suggested that the former might be subject to removal by lysine
deacetylases that recognize and remove N6-acetyllysine from histone and other proteins
[16,28-31]. Lysine deacetylases fall into several classes, including classes I and II that
share a common hydrolytic mechanism and are all inhibited by
suberoylanilidehydroxamic acid (SAHA), and the class III enzymes (i.e., sirtuins) that are
NAD*-dependent deacetylases [32,33]. In order to assess the activity of lysine
deacetylases with N -formyllysine substrates, TK6 cells were treated with SAHA and the
levels of N6-acetyllysine and N6-formyllysine were quantified. The results shown in
Figure 3-5A reveal that, while SAHA caused a 3-fold increase in the level of N6_
acetyllysine (4 to 14 per 103 lysines), lysine formylation was not affected. To assess
sirtuin activity against N6-formyllysine, we performed in vitro reactions of SIRTi with a
consensus peptide (GGAKRHR) containing N6-formyllysine or N -acetyllysine, and the
quantities of the modified and unmodified peptides were analyzed by LC-MS/MS. As
shown in Figure 3-5B, SIRT1 removed the acetyl modification completely to generate the
unmodified peptide, while only -10% (± 4%) of N6-formyllysine was removed.
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Figure 3-5. Effect of lysine deacetylases on N -formyllysine. (A) TK6 cells were
treated with the class I and class II histone deacetylase inhibitor, SAHA, as described
in Materials and Methods. Data represent mean ± SD for N=3, with asterisks denoting
statistically significant differences by Students t-test (p < 0.05). (B) Treatment of a
peptide substrate containing N6-formyllysine with the class III histone deacetylase,
SIRT1.
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Discussion
N -Formyllysine was first reported in 1985 in reactions of lysine with formaldehyde in
vitro [34] and, more recently, it was shown to form during in vitro silver-staining
procedures that involve the use of formaldehyde [35]. The recent discovery of N6_
formyllysine as a relatively abundant endogenous posttranslational modification of
histones and other nuclear proteins in cells [9-11] has raised questions about its
mechanism of formation and its potential for interfering with the regulatory function of
lysine N -acetylation. With respect to formation, we previously presented evidence that
N 6-formyllysine in histones could arise from reactions with 3'-formylphosphate residues
derived from DNA oxidation [9]. However, formaldehyde emerged as an alternative
source given the high reactivity of formaldehyde toward primary amines, such as the side
chain of lysine, and the potential for endogenous oxidation to convert a formaldehyde-
derived carbinolamine to a stable formamide (Figure 3-1). We have now demonstrated in
vitro and in cells that formaldehyde exposure leads to formation of N6 -formyllysine
residues in proteins. The fact that this modification arises in proteins other than
chromatin proteins and in cellular compartments other than the nucleus (Table 3-2)
suggests that 3'-formylphosphate residues in oxidized DNA do not account for all N6_
formyllysine adducts. This is consistent with recent studies in which N6-formyllysine
was detected in a protein oxidized with peroxynitrite in vitro [5]. The absence of
detectable N6-formyllysine arising from demethylation of N6-methyllysine species
(Figure 3-4C and Figure 3-S2) suggests that interruption of histone demethylation
reactions to form the carbinolamine precursor of N6-formyllysine occurs at low
frequency, or that the formaldehyde produced by complete lysine demethylation [23]
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does not occur at concentrations high enough to drive formylation of lysine or cause
substantial changes in N6-formyllysine levels detected by our current analytical method.
Furthermore, there is the possibility that the formaldehyde released during lysine
demethylation may be scavenged before it could react with lysines in histones. A recent
study reports that lysine-specific demethylase 1 (LSD1) is a folate binding protein [36],
which led the authors to hypothesize that the biological function of folate is to trap the
formaldehyde that is generated during lysine demethylation [36]. In addition, the
observation that the formaldehyde equivalent derived from histone demethylation might
not account for a significant portion of formyllysine residues is not surprising in light of
the abundance of formaldehyde from other cellular processes [20,22,23]. This is clear
from the high steady-state concentrations of formaldehyde in human plasma (13-97 pM)
[20].
The relative abundance of N -formyllysine in histone and other proteins (Tables
3-1 and 3-2) [9-11] and the persistence of these adducts in histone proteins provides
insights into both their source and their potential effects on cell function. The N6_
formyllysine residues are relatively evenly distributed among different classes of histone
proteins (Table 3-1), while the other functional modifications show very biased
distributions over a large frequency range, which is consistent with the known function
and conserved locations for lysine methylation and acetylation [16-18]. This random
distribution of formyllysine adducts in histone proteins suggests that they are adventitious
and not physiological. The fact that N -formyllysine levels are similar in histone and
non-nuclear proteins and in all cell compartments also suggests that the sources of this
protein modification are equally balanced in the various compartments and proteins, or
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that there is a single dominant source that distributes uniformly throughout the cell. With
regard to their persistence in cells, the N 6-formyllysine adducts appear to be refractory to
removal by histone deacetylase enzymes, which suggests that they will persist throughout
the life of individual histone proteins. Figure 3-6 summarizes our findings presented here
on N6-formyllysine adducts.
The isotope labeling studies revealed that lysine demethylation is not a source for
N 6-formyllysine in histones. Furthermore, our data suggest that N6-formyllysine is
refractory to removal by histone deacetylases, which is consistent with the persistence of
this pathological adduct throughout the life of individual histone proteins. That the N6_
formyllysine adducts have been observed at many of the known conserved functional
locations for lysine acetylation and methylation in histones [10,11] suggests that N6_
formyllysine could interfere with signaling processes associated with physiological
histone modifications [16,28]. The association of N6-formyllysine with a variety of
different cell and organismal processes, including metabolism, and the oxidative and
nitrosative stresses of inflammation [5,9], suggest that this adduct may play a role in
many pathophysiological processes in humans.
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Figure 3-6. Summary of findings on N6-formyllysine in histones. N6-formyllysine can
arise from reaction of lysine with the 3'-formyl phosphate residue derived from 5'-
oxidation of 2-deoxyribose in DNA or from reaction of lysine with formaldehyde. The
isotope labeling studies revealed that lysine demethylation is not a source for N6_
formyllysine in histones. Furthermore, our data suggest that N6-formyllysine is
refractory to removal by histone deacetylases, which is consistent with the persistence
of this pathological adduct throughout the life of individual histone proteins.
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Figure 3-S1. Reversed-phase HPLC fractionation of histone proteins. (A) HPLC
elution profile for histones extracted from TK6 cells, as described in Materials and
Methods section of Chapter 2. (B) SDS/PAGE analysis of the HPLC-fractionated
proteins shown in panel A. Lanes 1 and 2 are molecular weight markers, while lanes 3
and 4 refer to total histones from TK6 cells and calf thymus, respectively.
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Figure 3-S2. Lysine demethylation is not a source of N -formyllysine in histones. By
culturing TK6 cells in customized RPMI medium containing L-Methionine-([ C,2H3]-
methyl) for 20 days, it was shown that in contrast to predominant heavy isotope
labeling of mono-methyllysines (>90%), even as early as day 2, the level of N6-[13C,
2H]-formyllysine did not show an increase beyond the natural isotope abundance level
(-0.7% for [M+2] ion of N6-formyllysine), for any day.
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Abstract
The emergence of lysine N6-formylation as an abundant endogenous modification of
proteins has raised questions about its mechanism of formation. In addition to DNA
oxidation pathway previously reported (Jiang et al,. PNAS 104: 60-5, 2007), we
demonstrated in vitro and in cells that formaldehyde exposure leads to formation of N -
formyllysine residues in histone proteins (Chapter 3). Here, we extend our studies to
quantify N6-formyllysine protein adducts in rats exposed to isotope-labeled formaldehyde
by inhalation in order to calculate the contribution of exogenous versus endogenous
sources of formaldehyde to the total load of N6-formyllysine in cells. Moreover, our
studies complement previous studies of formaldehyde-induced N2-hydroxymethyl-dG
DNA adducts in exposed rats (Lu et al., Chem. Res. Toxicol. 24: 159-61, 2011), where we
aim to correlate the protein and DNA adducts given the carcinogenic potency of
formaldehyde. Using our ultrasensitive and specific liquid chromatography-coupled
tandem mass spectrometry method, we quantified endogenous and exogenous N 6_
fromyllysine protein adducts in total and fractionated proteins (cytoplasmic, membrane,
and nuclear) extracted from nasal epithelium, lung, and liver tissues of rats exposed to
single-dose, nose-only inhalation of 0.7, 2, 6, and 10 ppm [13C 2 H2 ]-formaldehyde for 6 h.
Similar to the DNA study, exogenous N -formyllysine adducts were only detectable in
nasal epithelium and not in distant tissues, with a dose-dependent formation in total as
well as in fractionated proteins. At 10 ppm exposure, nearly one-third of the total load of
N 6-formyllysine was derived from exogenous formaldehyde (0.9 ± 0.1 exogenous versus
2 ± 0.1 endogenous N 6-formyllysine adducts per 104 lysines in total proteins). Moreover,
there was a general decrease in exogenous adducts observed in nuclear proteins compared
to proteins obtained from other compartments, consistent with expected decrease of
inhaled formaldehyde concentration as it reacts with other biomolecules on its way to
nucleus. In histone proteins, the exogenous to endogenous adduct ratios for N6_
formyllysine are observed to occur about one third of ratios observed for DNA adduct,
although they follow a similar pattern of increase in response to formaldehyde dosage
(e.g., an increase in formaldehyde dosage from 6 ppm to 10 ppm, resulted in -3-fold
increase in exogenous versus endogenous ratios for both protein and DNA adducts). Our
formaldehyde studies shed light on yet another potential pathway associated with
formaldehyde toxicity and carcinogenicity, that is through epigenetic disruption of
histone proteins in cells by permanently formylating conserved sites of important
physiological modifications.
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Introduction
Aberrant protein modifications due to oxidants and electrophiles generated during
physiological or pathophysiological processes can lead to altered cellular processes and
progression of disease[1-5]. N6-Formylation of lysines has recently emerged as an
abundant adventitious protein modification [6-9], raising questions about its mechanism
of formation and biological consequences in cells. In histone proteins, the chemical
similarities of N 6-formyllysine to N6-acetyllysine suggest a disruptive role for the former
in signaling by histone acetylation, and the occurrence at many conserved lysine
acetylation and methylation sites along histone proteins [7] suggests possible interference
with the regulatory roles of post-translational modifications of these proteins. Studies to
date point to formaldehyde exposure as a major source of this adduct (Chapter 3) [10,11]
in addition to oxidative and nitrosative stresses of inflammation [6,9].
Formaldehyde exposure from environmental and occupational sources[12-14] as
well as endogenous cellular processes [13,15,16] make it an abundant electrophile in the
human body, as indicated by its concentration range of 13 to 97 pM in plasma [13,17].
Formaldehyde, classified as a known human carcinogen according to IARC [18,19], is
reported to cause squamous cell carcinoma in rats [20,21] with sufficient epidemiological
evidence for causing nasopharyngeal cancer but limited evidence for leukemia in humans
[13,18,19,22].
As a reactive aldehyde, formaldehyde readily forms adducts with nucleophilic
sites in DNA and proteins such as N2-hydroxymethyl-dG DNA adducts [12] and Schiff
bases on the side chain amine of lysines in proteins [23], in addition to extensive DNA-
protein and DNA-DNA crosslinks [24]. Our recent studies revealed N6-formyllysine
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formation in histone proteins of TK6 cells from the reaction of formaldehyde with the c-
amino group of lysine (Chapter 3). Our data showed a dose-dependent formation of N -
formyllysine residues as a function of formaldehyde concentration, with use of [13C, 2H2]-
formaldehyde revealing unchanged levels of N6-formyllysinespecies due to endogenous
sources.
Here, we extend our cell studies to an in vivo assessment of formaldehyde-
induced lysine N6-formylation in rats exposed by inhalation, with the use of [13C,2H2]-
formaldehyde to differentiate endogenous from exogenous adducts. Using our
ultrasensitive and specific liquid chromatography-coupled tandem mass spectrometry
(LC-MS/MS) method, we quantified the extent to which exposure to [1C,2H2]-
formaldehyde by inhalation induces N [13C, 2 H]-formyllysine. Endogenous N 6[ 2C, IH]-
formyllysine and exposure-induced N6_[ 13C, 2H]-formyllysine adducts were quantified in
total and fractionated (cytoplasmic, membrane, and nuclear) proteins extracted from nasal
epithelium, lung, and liver tissues of rats exposed to single-dose, nose-only inhalation of
0.7, 2, 6, and 10 ppm [ 3C2H2 ]-formaldehyde for 6 h. These studies complement previous
studies of [13C,2 H2 ]-formaldehyde-induced N 2-hydroxymethyl-dG DNA adducts in rats
from the same formaldehyde exposure studies [12], which allows us to correlate the
protein and DNA adducts arising with the same formaldehyde dose.
Application of our sensitive analytical methods revealed that exposure to
[ 13C,2H2 ]-formaldehyde vapor leads to the formation of exogenous N 6[3C, 2H]-
formyllysine in proteins of nasal epithelium, and that the exogenous adducts are formed
in proteins extracted from all cellular compartments in a dose-dependent manner, with
endogenous adducts dominating at all exposure conditions. Similar to the DNA study,
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the exogenous N6-formyllysine adducts were only detected in nasal epithelium and not in
distant tissues, with exogenous to endogenous adduct ratios in total proteins closely
matching increases seen in DNA adducts.
Materials and Methods
Materials. Rat tissues were provided by Prof. James Swenberg's Lab at University of
North Carolina at Chapel Hill [12]. Subcellular Protein Fractionation Kit was purchased
from Thermo Scientific (Waltham, MA). Lysine internal standard, 4,4,5,5,-[2H]-Lysine,
was purchased from Cambridge Isotope Laboratories (Andover, MA). N -Formyllysine
internal standard, 4,4,5,5-[2 H]-N 6-fonnyllysine, was synthesized from 4,4,5,5-[ 2H]-lysine
according to Jiang et al. [6]. Streptomyces griseus protease was purchased from Sigma-
Aldrich (St. Louis, MO).
Rat exposure to formaldehyde vapor. Rat exposure to [13C2H2 ]-formaldehyde was
performed at the Lovelace Respiratory Research Institute, Albuquerque, NM, by our
collaborator, Prof. James Swenberg, according to appropriate and approved protocols for
the use of vertebrate animals in experiments [12]. Fischer rats (6 w old, male) were
exposed to formaldehyde vapor by single-dose, nose-only inhalation of [ 3C2H2]-
formaldehyde for 6 h to produce final target exposure concentrations of 0.7, 2, 6, and 10
ppm. Rats were euthanized using an intraperitoneal barbiturate injection. For nasal
mucosa collection, the skull was split with a slight bias to one side (to preserve septal
mucosa) and maxilloturbinates collected, wrapped in aluminum foil, immediately snap
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frozen in liquid nitrogen and held at -80 0C pending analyses. Other tissue samples were
processed in a similar fashion.
Subcellular protein fractionation from tissue. For extracting proteins from tissues, ~10
mg of nasal epithelium, lung, or liver tissue was cut into small pieces and washed with
PBS. Tissues were homogenized using a Kontes all-glass Dounce homogenizer, with 10
strokes of a type B pestle, and proteins were separated into cytoplasmic, membrane,
soluble nuclear, and chromatin bound fractions using the Subcellular Protein
Fractionation Kit from Thermo Scientific. Total protein was obtained by centrifuging
tissue lysate, prior to fractionation, for 14000 x g for 15 min at 4 'C and collecting the
supernatant. Protein precipitation from each fraction was accomplished by adding 20%
v/v trichloroacetic acid and incubating overnight at 4 'C. Samples were centrifuged at
14000 x g for 10 min at 4 'C, washed once with ice-cold acetone containing 0.1% HCl,
and once with ice-cold acetone before being air-dried and stored at -20 0 C until use. N 6_
Formyllysine adducts were found to be stable under these conditions.
Enzymatic hydrolysis of proteins. Extracted proteins from tissues were dissolved in 50
p L of 100 mM ammonium bicarbonate buffer (pH 8.5), 4,4,5,5-[ 2H]-lysine (2 nmol), and
4,4,5,5-[2 H]-N 6-formyllysine (1 pmol) were added as internal standards, and the proteins
were hydrolyzed by addition of 2 p1 of freshly prepared S. griseus protease solution
(1Ig/pl) with incubation at 37'C for 16 h. Samples were dried under vacuum and
resuspended in 50 pL of water prior to mass spectrometry analysis.
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Quantification of amino acids. N6-Formyllysine amino acids in the resuspended protein
hydrolysates were quantified as a percentage of lysine content by liquid chromatography-
coupled mass spectrometry (LC-MS/MS). Analytes in total, cytoplasmic, and membrane
protein hydrolysates were analyzed without a pre-purification step. Nuclear protein
hydrolysates were first HPLC pre-purified to enhance the signal for the M+2 ion of N6_
formyllysine. HPLC pre-purification was done using an Agilent 1100 series system, with
an aqueous normal-phase Cogent diamond hydride column (2.1 x 150mm, 4pm) from
MicroSolv Technology Corporation (Eatontown, NJ), with mobile phase flow rate of 400
pL/min and column temperature of 20 'C. The solvent system was 0.1% acetic acid in
water (A) and 0.1% acetic acid in acetonitrile (B), with the elution starting at 100% B, the
gradient linearly decreased to 25% B over 30 min and held at 25% B for 3 additional min
before the column was re-equilibrated with 100% B for 7 min. For N6-formyllysine
quantification, an extended chromatography was used, in order to separate the M+l ion
of citrulline from M+2 ion of N6-formyllysine (Figure 2-8). The same solvent system of
0.1% acetic acid in water (A) and 0.1% acetic acid in acetonitrile (B) was used, with the
elution starting at 100% B, the gradient linearly decreased to 75% B over 75 min,
reaching 25% B over the next 3 min and 15% B by 83 min. The column was then re-
equilibrated with 100% B for 7 min. N6-Formyllysine and lysine were then analyzed
using an Agilent 6410 triple quadrupole mass spectrometer (MS/MS) equipped with an
electrospray ionization (ESI) source operated in positive ion mode. The operating
parameters were as follows: ESI capillary voltage, 4000 V; gas temperature, 350 'C;
drying gas flow, 12 L/min; and nebulizer pressure, 30 psi, with selected reaction
monitoring (SRM) transitions of m/z 175-+112 and for N6-formyllysine (with internal
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standard transition of m/z 179-> 116) and m/z 147-+130 for lysine (with internal standard
transition of m/z 151 ->134). The fragmentor voltage and collision energies were 105 V
and 10 V for N6-formyllysine and 100 V and 8 V for lysine, respectively.
Results
Quantification of background endogenous N6-formyllysine in tissues. In addition to
monitoring the formaldehyde-induced (exogenous) N -formyllysine modifications, it is
important to quantify the background (endogenous) levels of this protein adduct to parse
the contribution of exogenous formaldehyde sources to the total amount of lysine
formylation in cells. To this end, total proteins as well as fractionated proteins from
cytosolic, membrane, and nuclear compartments were extracted from nasal epithelium,
lung, and liver of exposed rats, and endogenous adducts were quantified using our
sensitive and specific LC-MS/MS method with the limits of detection of 1 fmol for N6_
formyllysine and 10 fmol for lysine. Table 4-1 summarizes the background levels of N6_
formyllysine in all proteins analyzed. There are similar levels of endogenous adducts
among different types of tissue analyzed with a range of 2-4 N 6-formyllysine residues per
104 lysines. Each tissue shows similar levels in control rats and rats exposed to the
highest dose of 10 ppm [13C, 2H2 ]-formaldehyde, which indicates that exposure to
formaldehyde did not affect the endogenous adduct levels.
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Table 4-1. Quantification of endogenous N6-formyllysine protein adducts in total and
fractionated proteins.I
Protein source Nasal Epithelium Lung Liver
Dose 0 ppm 9.7 ppm 0 ppm 9.7 ppm 0 ppm 9.7 ppm
Total protein 2 ±0.12 2 ±0.1 4 ±0.2 3 ±0.4 3 ±0.1 3 ±0.5
Cytoplasmic 2 ±0.4 2 ±0.4 4 ±0.6 4 ±0.6 4 ±0.5 4 ±0.1
Membrane 3 ±0.8 2 ±0.4 3 ±0.5 3 ±0.4 3 ±0.3 3 ±0.2
Soluble nuclear 2 ±0.3 2 ±1.0 4 ±1.0 4 ±0.3 4 ±0.8 4 ±0.7
Chromatin bound 2 ±0.1 2 ±0.4 3 ±1.0 3 ±0.2 4 ±0.5 3 ±0.3
Column titles denote endogenous N6-formyllysine modifications in each tissue analyzed
(for control versus 9.7 ppm [13C, 2H2]-formaldehyde exposed rats).
2Data are expressed as adducts per 104 total lysines and represent mean ± SD for 3 rats.
Formaldehyde-induced formation of exogenous N6-formyllysine adducts. The
formation of N6-formyllysine from inhaled ["C,2H2].-.formaldehyde was monitored using
the m/z 177-> 114 transition for N6- 13c 2H]-formyllysine that is 2 mass units heavier than
the endogenous adduct, as noted in Chapter 3, with the 4,4,5,5-[ 2H]-N 6-formyllysine
internal standard monitored at m/z 179 ->116 (Figure 4-1). Exogenously-derived N6_
formyllysine adducts were only detected in proteins extracted from nasal epithelium and
not in distant tissues of lung and liver. In all samples analyzed from lung and liver
tissues, the exogenous adducts did not show an increase beyond the natural isotope
abundance level of ~0.7% for [M+2] ion of N6-formyllysine. In addition to total proteins,
an analysis of proteins in cytosolic, membrane, and nuclear compartments revealed the
dose-dependent formation of exogenous N -formyllysine species in all locations (Table
4-2 and Figure 4-2). Data show that, at all exposures, the endogenous adducts dominate.
106
Chapter 4: Formaldehyde-induced formation of M-formyllysine protein adducts in rats
Control 10 ppm Formaldehyde
x102 x10 2
Endogenous Endogenous
7 m/z 175 -rmz 112 7 m/z 175 -+ m/z 112
c5 5
03
50 55 60 65 ' 0 O o
Retention time, min Retention time, min
Figure 4-1. Inhalation of [IC,2H2]-formaldehyde distinguishes exogenous from
endogenous sources of N6-formyllysine in rats. LC-MS/MS analysis showing signals
for the three isotopomeric N6-formyllysine species, in cytoplasmic proteins extracted
from nasal epithelium, as described in Materials and Methods.
There is a clear dose-response relationship for lysine N6-formylation across the range of
inhaled formaldehyde doses (0.7, 2, 6, 10 ppm) (Figure 4-2), with exogenous adducts in
total proteins rising from < 3% of endogenous adducts to > 40% for a 14-fold increase in
formaldehyde dosage (0.7 to 10 ppm). At all exposure levels, the ratio of exogenous to
endogenous N6-formyllysine adducts in all proteins, except nuclear proteins, closely
correlate with ratios of exogenous and endogenous N2-hydroxymethyl-dG DNA adducts
determined by Swenberg and coworkers [12]. For instance, N6-formyllysine ratios of
0.15 and 0.4 in total protein closely match the DNA adduct ratios of 0.2 and 0.6, for 6
and 10 ppm exposures, respectively.
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Table 4-2. Quantification of endogenous and exo enous N6-formyllysine protein
adducts in nasal epithelium from rats exposed to [I C, 2H2]-formaldehyde.
Dose 0.7 ppm 2 ppm 5.8 ppm 9.7 ppm
Adduct type Endo' Exog Endo Exog Endo Exog Endo Exog
Total Protein 2 0.06± 2± 0.2± 2± 0.3± 2± 0.9±0.12 0.04 0.2 0.02 0.4 0.04 0.1 0.1
. 2 0.05± 3± 0.2± 2± 0.4± 2± 0.8±
Cytoplasmic 0.3 0.04 0.2 0.07 0.8 0.2 0.4 0.1
2 0.06± 2± 0.2± 3± 0.3± 2± 0.7±
Membrane 0.3 0.02 0.8 0.03 0.2 0.02 0.4 0.2
Soluble nuclear 2 0.05± 2± 0.2± 4± 0.4± 2± 0.5±0.3 0.05 1.0 0.1 0.4 0.2 1.0 0.2
2 0.02± 2± 0.03 2± 0.05 2± 0.2±Chromatinbound 0.4 0.02 0.8 0.01 0.1 0.05 0.4 0.01
Column titles denote endogenous or exo
each [13C,2H 2]-formaldehyde exposure dose.
genous N6-formyllysine modifications for
2Data are expressed as modifications per 104 total lysines and represent mean ± SD
for 3 rats.
As shown in Table 4-2 and Figure 4-2, there is a general decrease in adduct levels in
nuclear proteins compared to proteins from other cell compartments. For example, a 10
ppm formaldehyde exposure produced 0.2 exogenous N6-formyllysine adducts per 104
lysines in chromatin proteins compared to 0.7 and 0.8 residues in cytoplasmic and
membrane fractions, respectively (p < 0.05).
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Fi ure 4-2. [ 3C, 2H2]-Formaldehyde causes a dose-response increase in exogenous
N -formyllysine adducts. Ratios of exogenous versus endogenous N -formyllysine
protein adducts in the nasal epithelium of rats exposed to [13 C,2H2 ]-formaldehyde for
6h, as described in Materials and Methods. Data represent mean ± SD for N=3.
Discussion
The results of these in vivo studies point to several important features of N6-formyllysine
formation and formaldehyde toxicity. While originally described as an adventitious
protein modification of histone and other nuclear proteins [6-8], N6-formylation of lysine
has been shown to occur globally in proteins from different cellular compartments as well
as plasma proteins (Chapter 3). These observations, together with the in vitro
formaldehyde studies of Chapter 3 and the relatively high levels of formaldehyde
exposure from environmental [12-14] and endogenous [13,15,16] sources, point to
formaldehyde as a major source of N6-formyllysine adducts in cells, as compared to DNA
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oxidation pathway previously reported. Here, our in vivo assessment of N6-formyllysine
formation in rats exposed to formaldehyde by inhalation is consistent with our previous
conclusion of formaldehyde as a source of lysine N6-formylation. Interestingly, the
background levels of N6-formyllysine species due to endogenous sources were unaffected
even at the highest formaldehyde exposure dosage, which suggests that the formaldehyde
doses used for exposure do not alter the cellular production of formaldehyde.
The observation that background N 6-formyllysine levels are similar in proteins
from all cellular compartments suggests that the sources of this protein modification are
equally balanced in the various compartments, consistent with cellular abundance of
formaldehyde due to environmental and endogenous sources [12-16]. The dose-
dependent formation of exogenous N6_[ 13C,2H]-formyllysine adducts in all
compartments, with decreased levels in nucleus, is consistent with exogenous stable
isotope-labeled formaldehyde being the source, as inhaled formaldehyde concentration is
expected to decrease on the way to nucleus by reacting with other biomolecules.
To further correlate protein and DNA adducts given the carcinogenic potency of
formaldehyde, exogenous/endogenous ratios of N 6-formyllysine residues in histone
proteins are plotted against the published values of N2-hydroxymethyl-dG DNA adducts
[12], as shown in Figure 4-3. Data reveal that DNA adducts dominate histone adducts for
the same concentration of formaldehyde. For instance, for the case of 10 ppm exposure,
the exogenous to endogenous N2-hydroxymethyl-dGadduct ratio is more than 3-fold of
that for N6-formyllysine (i.e., ~0.6 versus less than 0.2). However, they both follow the
same pattern of increase as a response to formaldehyde exposure. For example, going
from 2 ppm to 10 ppm, and from 6 ppm to 10 ppm formaldehyde exposure doses result in
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Figure 4-3. Comparison of exposure-response plots for ratios of exogenous to
endogenous adducts in DNA (obtained from [12]) and histone proteins in the nasal
epithelium of rats exposed to [13C,2H2 ]-formaldehyde. Data for N6-formyllysine
adducts represent mean ± SD for 3 rats.
same 20-fold and 3-fold ratio increases, respectively, in both DNA and protein adducts
(Figure 4-3).
The analysis of N6-formyllysine adducts sheds light on the mechanisms of
formaldehyde toxicity. The protein adduct data complement previous studies of
formaldehyde-induced DNA adducts in rats[12], with our results showing strong
correlations between protein and DNA adduct formation during formaldehyde exposure.
Our results show that, similar to N2-hydroxymethyl-dG DNA adducts, the exogenously-
derived N6-formyllysine residues were only detected in nasal epithelium and not in
distant tissues of lung and liver, with a dose-dependent formation of exogenous adducts
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in total proteins as well as proteins from specific cellular compartments (Figure 4-2 and
Table 4-2). With the exception of nuclear proteins, the levels of N6-formyllysine
formation in proteins closely correlates with N2-hydroxymethyl-dG adduct formation in
DNA. However, as shown in Figure 4-3,the proportion of DNA adducts derived from
exogenous formaldehyde was significantly higher than that for the histone adducts for the
same concentration of formaldehyde, even though theoretically the same number of
exogenous formaldehyde molecules should reach DNA and histones. This difference in
ratios could be due to several factors such as DNA guanine content compared to histone
lysine content, faster kinetics of N2-hydroxymethyl-dGformation versus N -formyllysine
formation, as well as possible greater solvent exposure of guanine N2-positions compared
to lysine amino side chains in histone proteins. Nonetheless, both N2-hydroxymethyl-dG
and N 6-formyllysine adducts follow the same pattern of increase as a response to
formaldehyde dosage (Figure 4-3).
There have been extensive studies to date on possible mechanisms for
formaldehyde toxicity and carcinogenicity. For instance, some studies found a non-linear
dose-dependent formation of DNA damage products in rats and non-human primates
exposed to formaldehyde inhalation [12,17,25,26] with other studies showing long term
formaldehyde exposure of higher than 6 ppm dosage resulting in a substantial increases
in squamous cell carcinomas in rats [20,21,27]. On the path to understanding
formaldehyde's biological consequences, our results shed light on yet another pathway,
that is through formation of N6-formyllysine adducts in histones. N6-Formyllysine
adducts have been mapped on many conserved lysine acetylation and methylation sites
along histones [7,8]. This observation along with chemical similarity of lysine N6_
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formylation to lysine N -acetylation, as well as our results showing N6-formyllysine is
refractory to removal by histone deacetylases (Chapter 3) suggests that N6 -formyllysine
could interfere with the epigenetic roles associated with physiological histone
modifications [28,29]. In other words, our studies suggest that prolonged exposure to
formaldehyde from environmental and occupational sources can drive substantial and
permanent formylation of conserved sites of important physiological modifications in
histone proteins, thus interfering with their regulatory roles and further contributing to
toxicity and carcinogenicity associated with formaldehyde exposure.
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The recent discovery of N6-formyllysine as a relatively abundant endogenous
secondary modification of histones and other nuclear proteins [1-3] has raised questions
about its mechanism of formation and its potential for interfering with the regulatory
roles of these proteins, particularly in terms of disrupting histone acetylation signaling
[4,5] due to chemical similarity of N6-formyllysine to N6-acetyllysine (Figure 1-1). With
respect to formation, we considered formaldehyde as a source because of its high
reactivity toward primary amines, such as the side chain of lysine, and the potential for
endogenous oxidation converting the formaldehyde-derived carbinolamine to a
formamide bond (Figure 3-1). Using our ultrasensitive and specific liquid
chromatography-coupled tandem mass spectrometry method to quantify N6-formyllysine
lesions in proteins, we presented evidence for formaldehyde being a major source of this
pathological protein modification in addition to products of oxidative DNA damage
previously reported [1]. More specifically, the work presented in this thesis demonstrated
in vitro as well as in vivo (Chapters 3 and 4) that formaldehyde exposure leads to a dose-
dependent lysine N6-formylation in all cellular proteins, with the use of [ 3C,2H2]-
formaldehyde to differentiate endogenous from exogenous adducts. Indeed, our study of
formaldehyde exposure in TK6 cells showed that the exogenous formaldehyde
contributed to half of the total load of formyllysine in histone proteins at 10 mM
concentration (Chapter 3), while in rats exposed to 10 ppm formaldehyde by inhalation,
nearly one-third of the total load of N6-formyllysine was derived from exogenous sources
in total proteins extracted from nasal epithelium (Chapter 4).
The formaldehyde studies of Chapters 3 and 4 and the high incident of
formaldehyde exposure due to environmental [6-8] and endogenous [7,9,10] sources
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together with our discovery of global lysine formylation occurring in plasma proteins and
proteins from all cellular compartments (Tables 3-2 and 4-1), point to formaldehyde as
the major source of N6-formyllysine adducts as compared to DNA oxidation pathway [1].
The fact that N6-formyllysine levels are similar in histone and non-nuclear proteins and in
all cell compartments also suggests that the sources of this protein modification are
equally balanced in the various compartments and proteins, or that there is a single
dominant source that distributes uniformly throughout the cell. Though it is not yet
possible to distinguish N6-formyllysine adducts arising from endogenous formaldehyde
versus other sources, the fact that human serum concentration of formaldehyde occur in
the range of 10 to 100 ptM [7,11,12] is consistent with formylation of lysine in vivo.
In terms of other sources of this adduct, we considered disrupted histone
demethylation that would leave the carbinolamine precursor of N 6-formyllysine for
subsequent oxidation and the formaldehyde produced by complete lysine demethylation
[10]. However, we presented evidence in Chapter 3 that lysine demethylation process
does not serve as a source of lysine N6-formylation. The absence of detectable N6_
formyllysine arising from N6-methyllysine species (Figure 3-4C) suggests that disrupted
histone demethylation occurs at low frequency, or that the formaldehyde produced at the
last step of lysine demethylation does not occur at concentrations high enough to drive
formylation of lysine or cause substantial changes in N6-formyllysine levels detected by
our current analytical methods. In addition, there is the possibility that the formaldehyde
released during lysine demethylation may be scavenged before it could react with lysines
in histone proteins. Indeed, a recent study reports lysine-specific demethylase 1 (LSD1)
as a folate binding protein and suggests folate serves as a trap for the formaldehyde
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generated during lysine demethylation [13].
With regard to N6-formyllysine persistence in cells, there is still no evidence
supporting the enzymatic removal of N6-formyllysine. Our investigation of histone
deacetylases (Chapter 3) revealed that despite chemical similarity of N -formyllysine to
N 6-acetyllysine, the former is not removed by histone deacetylases, suggesting that they
will persist throughout the life of individual histone proteins. Further, the [2 H]-N -
formyllysine dilution studies (Chapter 2) indicate that at one extreme N6-formyllysine
persists in cells for the life of histone proteins and at the other extreme, its steady state
levels doesn't change as it is formed and removed at the same frequency. Although the
studies presented in this thesis point to the stability of lysine N6-formylation in proteins,
we cannot rule out the possibility of an enzyme that would remove this modification from
selected conserved lysine sites in histone proteins, resulting in small change in the
quantity of formyllysine that is simply not detectable by our current analytical method.
With respect to pathological consequences of N6-formyllysine in cells, the
abundance of lysine N6-formylation in histone proteins points to its potential for
epigenetic alterations in gene expression. The observation that N6-formyllysine adducts
are randomly and relatively evenly distributed among different classes of histone
proteins, as opposed to the very biased distributions of other functional modifications
(Table 3-1), suggests that they are adventitious and not physiological. The high
abundance of lysine N6-formylation in histone proteins (Table 2-3) as well as its
occurrence on many conserved functional locations for lysine acetylation and methylation
[2,3] suggest a disruptive role for N6 -formyllysine with regards to signaling processes
associated with physiological histone modifications [4,5]. In other words, if N6_
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formyllysine is not removed, it could accumulate to significant levels in histone proteins
and interfere with their epigenetic regulatory processes through sabotaging the lysine
acetylation signaling or blocking the conserved lysines sites and preventing them from
undergoing important physiological modifications needed for proper functions of cells.
This potential pathological consequence of N6-formyllysine in cells is consistent with
toxicity and carcinogenicity associated with formaldehyde. Indeed, on the path to
understanding formaldehyde's biological consequences, our results shed light on yet
another pathway, that is through formation of N6-formyllysine adducts in histone
proteins. This potential epigenetic mechanism of disruption of cell function together with
the association of N6-formyllysine with oxidative and nitrosative stresses of inflammation
[1,14], suggest that this adduct may play a role in many pathophysiological processes in
humans.
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